The present disclosure relates to medical devices, and more particularly, robotic systems and related methods and devices.
When performing cranial/brain surgery, the soft tissues of the brain can easily shift. Such shifting may occur, for example, after the surgeon penetrates the skull and intracranial pressure changes. Tracking structures internal to the brain using markers attached external to the skull and/or based on registration from a preoperative scan may thus be inaccurate if such shifting occurs. Stated in other words, during surgery, brain structures may shift/distort relative to a pre-operative image scan, thereby reducing accuracy of planned trajectories determined based on the pre-operative image scan.
According to some embodiments of inventive concepts, a robotic system may include a robotic actuator configured to position a surgical end-effector with respect to an anatomical volume of a patient, and a controller coupled with the robotic actuator. The controller may be configured to provide first data for a first 3-dimensional (3D) image scan of the anatomical volume, with the first data identifying a blood vessel node in a first coordinate system for the first 3D image scan. The controller may also be configured to provide second data for a second 3D image scan of the anatomical volume, with the second data identifying the blood vessel node in a second coordinate system for the second 3D image scan. The controller may be further configured to co-register the first and second coordinate systems for the first and second 3D image scans of the anatomical volume using the blood vessel node identified in the first data and in the second data as a fiducial. In addition, the controller may be configured to control the robotic actuator to move the end-effector to a target trajectory relative to the anatomical volume based on co-registering the first and second coordinate systems for the first and second 3D image scans using the blood vessel node.
According to some other embodiments of inventive concepts, a method may be provided to operate a medical system. First data may be provided for a first 3-dimensional (3D) image scan of an anatomical volume, with the first data identifying a blood vessel node in a first coordinate system for the first 3D image scan. Second data may be provided for a second 3D image scan of the anatomical volume, with the second data identifying the blood vessel node in a second coordinate system for the second 3D image scan. The first and second coordinate systems for the first and second 3D image scans of the anatomical volume may be co-registered using the blood vessel node identified in the first data and in the second data as a fiducial.
Other methods and related systems, and corresponding methods and computer program products according to embodiments of the inventive subject matter will be or become apparent to one with skill in the art upon review of the following drawings and detailed description. It is intended that all such systems, and corresponding methods and computer program products be included within this description, be within the scope of the present inventive subject matter, and be protected by the accompanying claims. Moreover, it is intended that all embodiments disclosed herein can be implemented separately or combined in any way and/or combination.
The accompanying drawings, which are included to provide a further understanding of the disclosure and are incorporated in a constitute a part of this application, illustrate certain non-limiting embodiments of inventive concepts. In the drawings:
It is to be understood that the present disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the description herein or illustrated in the drawings. The teachings of the present disclosure may be used and practiced in other embodiments and practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Unless specified or limited otherwise, the terms “mounted,” “connected,” “supported,” and “coupled” and variations thereof are used broadly and encompass both direct and indirect mountings, connections, supports, and couplings. Further, “connected” and “coupled” are not restricted to physical or mechanical connections or couplings.
The following discussion is presented to enable a person skilled in the art to make and use embodiments of the present disclosure. Various modifications to the illustrated embodiments will be readily apparent to those skilled in the art, and the principles herein can be applied to other embodiments and applications without departing from embodiments of the present disclosure. Thus, the embodiments are not intended to be limited to embodiments shown, but are to be accorded the widest scope consistent with the principles and features disclosed herein. The following detailed description is to be read with reference to the figures, in which like elements in different figures have like reference numerals. The figures, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the embodiments. Skilled artisans will recognize the examples provided herein have many useful alternatives and fall within the scope of the embodiments.
Turning now to the drawing,
With respect to the other components of the robot 102, the display 110 can be attached to the surgical robot 102 and in other exemplary embodiments, display 110 can be detached from surgical robot 102, either within a surgical room with the surgical robot 102, or in a remote location. End-effector 112 may be coupled to the robot arm 104 and controlled by at least one motor. In exemplary embodiments, end-effector 112 can comprise a guide tube 114, which is able to receive and orient a surgical instrument 608 (described further herein) used to perform surgery on the patient 210. As used herein, the term “end-effector” is used interchangeably with the terms “end-effectuator” and “effectuator element.” Although generally shown with a guide tube 114, it will be appreciated that the end-effector 112 may be replaced with any suitable instrumentation suitable for use in surgery. In some embodiments, end-effector 112 can comprise any known structure for effecting the movement of the surgical instrument 608 in a desired manner.
The surgical robot 102 is able to control the translation and orientation of the end-effector 112. The robot 102 is able to move end-effector 112 along x-, y-, and z-axes, for example. The end-effector 112 can be configured for selective rotation about one or more of the x-, y-, and z-axis, and a Z Frame axis (such that one or more of the Euler Angles (e.g., roll, pitch, and/or yaw) associated with end-effector 112 can be selectively controlled). In some exemplary embodiments, selective control of the translation and orientation of end-effector 112 can permit performance of medical procedures with significantly improved accuracy compared to conventional robots that use, for example, a six degree of freedom robot arm comprising only rotational axes. For example, the surgical robot system 100 may be used to operate on patient 210, and robot arm 104 can be positioned above the body of patient 210, with end-effector 112 selectively angled relative to the z-axis toward the body of patient 210.
In some exemplary embodiments, the position of the surgical instrument 608 can be dynamically updated so that surgical robot 102 can be aware of the location of the surgical instrument 608 at all times during the procedure. Consequently, in some exemplary embodiments, surgical robot 102 can move the surgical instrument 608 to the desired position quickly without any further assistance from a physician (unless the physician so desires). In some further embodiments, surgical robot 102 can be configured to correct the path of the surgical instrument 608 if the surgical instrument 608 strays from the selected, preplanned trajectory. In some exemplary embodiments, surgical robot 102 can be configured to permit stoppage, modification, and/or manual control of the movement of end-effector 112 and/or the surgical instrument 608. Thus, in use, in exemplary embodiments, a physician or other user can operate the system 100, and has the option to stop, modify, or manually control the autonomous movement of end-effector 112 and/or the surgical instrument 608. Further details of surgical robot system 100 including the control and movement of a surgical instrument 608 by surgical robot 102 can be found in co-pending U.S. Pat. No. 9,782,229, the disclosure of which is hereby incorporated herein by reference in its entirety.
The robotic surgical system 100 can comprise one or more tracking markers 118 configured to track the movement of robot arm 104, end-effector 112, patient 210, and/or the surgical instrument 608 in three dimensions. In exemplary embodiments, a plurality of tracking markers 118 can be mounted (or otherwise secured) thereon to an outer surface of the robot 102, such as, for example and without limitation, on base 106 of robot 102, on robot arm 104, and/or on the end-effector 112. In exemplary embodiments, at least one tracking marker 118 of the plurality of tracking markers 118 can be mounted or otherwise secured to the end-effector 112. One or more tracking markers 118 can further be mounted (or otherwise secured) to the patient 210. In exemplary embodiments, the plurality of tracking markers 118 can be positioned on the patient 210 spaced apart from the surgical field 208 to reduce the likelihood of being obscured by the surgeon, surgical tools, or other parts of the robot 102. Further, one or more tracking markers 118 can be further mounted (or otherwise secured) to the surgical tools 608 (e.g., a screw driver, dilator, implant inserter, or the like). Thus, the tracking markers 118 enable each of the marked objects (e.g., the end-effector 112, the patient 210, and the surgical tools 608) to be tracked by the robot 102. In exemplary embodiments, system 100 can use tracking information collected from each of the marked objects to calculate the orientation and location, for example, of the end-effector 112, the surgical instrument 608 (e.g., positioned in the tube 114 of the end-effector 112), and the relative position of the patient 210.
The markers 118 may include radiopaque or optical markers. The markers 118 may be suitably shaped include spherical, spheroid, cylindrical, cube, cuboid, or the like. In exemplary embodiments, one or more of markers 118 may be optical markers. In some embodiments, the positioning of one or more tracking markers 118 on end-effector 112 may increase/maximize accuracy of positional measurements by serving to check or verify a position of end-effector 112. Further details of surgical robot system 100 including the control, movement and tracking of surgical robot 102 and of a surgical instrument 608 can be found in U.S. patent publication No. 2016/0242849, the disclosure of which is incorporated herein by reference in its entirety.
Exemplary embodiments include one or more markers 118 coupled to the surgical instrument 608. In exemplary embodiments, these markers 118, for example, coupled to the patient 210 and surgical instruments 608, as well as markers 118 coupled to the end-effector 112 of the robot 102 can comprise conventional infrared light-emitting diodes (LEDs) or an Optotrak® diode capable of being tracked using a commercially available infrared optical tracking system such as Optotrak®. Optotrak® is a registered trademark of Northern Digital Inc., Waterloo, Ontario, Canada. In other embodiments, markers 118 can comprise conventional reflective spheres capable of being tracked using a commercially available optical tracking system such as Polaris Spectra. Polaris Spectra is also a registered trademark of Northern Digital, Inc. In an exemplary embodiment, the markers 118 coupled to the end-effector 112 are active markers which comprise infrared light-emitting diodes which may be turned on and off, and the markers 118 coupled to the patient 210 and the surgical instruments 608 comprise passive reflective spheres.
In exemplary embodiments, light emitted from and/or reflected by markers 118 can be detected by camera 200 and can be used to monitor the location and movement of the marked objects. In alternative embodiments, markers 118 can comprise a radio-frequency and/or electromagnetic reflector or transceiver and the camera 200 can include or be replaced by a radio-frequency and/or electromagnetic transceiver.
Similar to surgical robot system 100,
Input power is supplied to system 300 via a power source 548 which may be provided to power distribution module 404. Power distribution module 404 receives input power and is configured to generate different power supply voltages that are provided to other modules, components, and subsystems of system 300. Power distribution module 404 may be configured to provide different voltage supplies to platform interface module 406, which may be provided to other components such as computer 408, display 304, speaker 536, driver 508 to, for example, power motors 512, 514, 516, 518 and end-effector 310, motor 510, ring 324, camera converter 542, and other components for system 300 for example, fans for cooling the electrical components within cabinet 316.
Power distribution module 404 may also provide power to other components such as tablet charging station 534 that may be located within tablet drawer 318. Tablet charging station 534 may be in wireless or wired communication with tablet 546 for charging table 546. Tablet 546 may be used by a surgeon consistent with the present disclosure and described herein.
Power distribution module 404 may also be connected to battery 402, which serves as temporary power source in the event that power distribution module 404 does not receive power from input power 548. At other times, power distribution module 404 may serve to charge battery 402 if necessary.
Other components of platform subsystem 502 may also include connector panel 320, control panel 322, and ring 324. Connector panel 320 may serve to connect different devices and components to system 300 and/or associated components and modules. Connector panel 320 may contain one or more ports that receive lines or connections from different components. For example, connector panel 320 may have a ground terminal port that may ground system 300 to other equipment, a port to connect foot pedal 544 to system 300, a port to connect to tracking subsystem 532, which may comprise position sensor 540, camera converter 542, and cameras 326 associated with camera stand 302. Connector panel 320 may also include other ports to allow USB, Ethernet, HDMI communications to other components, such as computer 408.
Control panel 322 may provide various buttons or indicators that control operation of system 300 and/or provide information regarding system 300. For example, control panel 322 may include buttons to power on or off system 300, lift or lower vertical column 312, and lift or lower stabilizers 520-526 that may be designed to engage casters 314 to lock system 300 from physically moving. Other buttons may stop system 300 in the event of an emergency, which may remove all motor power and apply mechanical brakes to stop all motion from occurring. Control panel 322 may also have indicators notifying the user of certain system conditions such as a line power indicator or status of charge for battery 402.
Ring 324 may be a visual indicator to notify the user of system 300 of different modes that system 300 is operating under and certain warnings to the user.
Computer subsystem 504 includes computer 408, display 304, and speaker 536. Computer 504 includes an operating system and software to operate system 300. Computer 504 may receive and process information from other components (for example, tracking subsystem 532, platform subsystem 502, and/or motion control subsystem 506) in order to display information to the user. Further, computer subsystem 504 may also include speaker 536 to provide audio to the user.
Tracking subsystem 532 may include position sensor 504 and converter 542. Tracking subsystem 532 may correspond to camera stand 302 including camera 326 as described with respect to
Motion control subsystem 506 may be configured to physically move vertical column 312, upper arm 306, lower arm 308, or rotate end-effector 310. The physical movement may be conducted through the use of one or more motors 510-518. For example, motor 510 may be configured to vertically lift or lower vertical column 312. Motor 512 may be configured to laterally move upper arm 308 around a point of engagement with vertical column 312 as shown in
Moreover, system 300 may provide for automatic movement of vertical column 312, upper arm 306, and lower arm 308 through a user indicating on display 304 (which may be a touchscreen input device) the location of a surgical instrument or component on a three dimensional image of the patient's anatomy on display 304. The user may initiate this automatic movement by stepping on foot pedal 544 or some other input means.
A tracking array 612 may be mounted on instrument 608 to monitor the location and orientation of instrument tool 608. The tracking array 612 may be attached to an instrument 608 and may comprise tracking markers 804. As best seen in
Markers 702 may be disposed on or within end-effector 602 in a manner such that the markers 702 are visible by one or more cameras 200, 326 or other tracking devices associated with the surgical robot system 100, 300, 600. The camera 200, 326 or other tracking devices may track end-effector 602 as it moves to different positions and viewing angles by following the movement of tracking markers 702. The location of markers 702 and/or end-effector 602 may be shown on a display 110, 304 associated with the surgical robot system 100, 300, 600, for example, display 110 as shown in
For example, as shown in
In addition, in exemplary embodiments, end-effector 602 may be equipped with infrared (IR) receivers that can detect when an external camera 200, 326 is getting ready to read markers 702. Upon this detection, end-effector 602 may then illuminate markers 702. The detection by the IR receivers that the external camera 200, 326 is ready to read markers 702 may signal the need to synchronize a duty cycle of markers 702, which may be light emitting diodes, to an external camera 200, 326. This may also allow for lower power consumption by the robotic system as a whole, whereby markers 702 would only be illuminated at the appropriate time instead of being illuminated continuously. Further, in exemplary embodiments, markers 702 may be powered off to prevent interference with other navigation tools, such as different types of surgical instruments 608.
The manner in which a surgeon 120 may place instrument 608 into guide tube 606 of the end-effector 602 and adjust the instrument 608 is evident in
End-effector 602 may mechanically interface and/or engage with the surgical robot system and robot arm 604 through one or more couplings. For example, end-effector 602 may engage with robot arm 604 through a locating coupling and/or a reinforcing coupling. Through these couplings, end-effector 602 may fasten with robot arm 604 outside a flexible and sterile barrier. In an exemplary embodiment, the locating coupling may be a magnetically kinematic mount and the reinforcing coupling may be a five bar over center clamping linkage.
With respect to the locating coupling, robot arm 604 may comprise mounting plate 1216, which may be non-magnetic material, one or more depressions 1214, lip 1218, and magnets 1220. Magnet 1220 is mounted below each of depressions 1214. Portions of clamp 1204 may comprise magnetic material and be attracted by one or more magnets 1220. Through the magnetic attraction of clamp 1204 and robot arm 604, balls 1208 become seated into respective depressions 1214. For example, balls 1208 as shown in
With respect to the reinforcing coupling, portions of clamp 1204 may be configured to be a fixed ground link and as such clamp 1204 may serve as a five bar linkage. Closing clamp handle 1206 may fasten end-effector 602 to robot arm 604 as lip 1212 and lip 1218 engage clamp 1204 in a manner to secure end-effector 602 and robot arm 604. When clamp handle 1206 is closed, spring 1210 may be stretched or stressed while clamp 1204 is in a locked position. The locked position may be a position that provides for linkage past center. Because of a closed position that is past center, the linkage will not open absent a force applied to clamp handle 1206 to release clamp 1204. Thus, in a locked position, end-effector 602 may be robustly secured to robot arm 604.
Spring 1210 may be a curved beam in tension. Spring 1210 may be comprised of a material that exhibits high stiffness and high yield strain such as virgin PEEK (poly-ether-ether-ketone). The linkage between end-effector 602 and robot arm 604 may provide for a sterile barrier between end-effector 602 and robot arm 604 without impeding fastening of the two couplings.
The reinforcing coupling may be a linkage with multiple spring members. The reinforcing coupling may latch with a cam or friction based mechanism. The reinforcing coupling may also be a sufficiently powerful electromagnet that will support fastening end-effector 102 to robot arm 604. The reinforcing coupling may be a multi-piece collar completely separate from either end-effector 602 and/or robot arm 604 that slips over an interface between end-effector 602 and robot arm 604 and tightens with a screw mechanism, an over center linkage, or a cam mechanism.
Referring to
To track the position of the patient 210, a patient tracking device 116 may include a patient fixation instrument 1402 to be secured to a rigid anatomical structure of the patient 210 and a dynamic reference base (DRB) 1404 may be securely attached to the patient fixation instrument 1402. For example, patient fixation instrument 1402 may be inserted into opening 1406 of dynamic reference base 1404. Dynamic reference base 1404 may contain markers 1408 that are visible to tracking devices, such as tracking subsystem 532. These markers 1408 may be optical markers or reflective spheres, such as tracking markers 118, as previously discussed herein.
Patient fixation instrument 1402 is attached to a rigid anatomy of the patient 210 and may remain attached throughout the surgical procedure. In an exemplary embodiment, patient fixation instrument 1402 is attached to a rigid area of the patient 210, for example, a bone that is located away from the targeted anatomical structure subject to the surgical procedure. In order to track the targeted anatomical structure, dynamic reference base 1404 is associated with the targeted anatomical structure through the use of a registration fixture that is temporarily placed on or near the targeted anatomical structure in order to register the dynamic reference base 1404 with the location of the targeted anatomical structure.
A registration fixture 1410 is attached to patient fixation instrument 1402 through the use of a pivot arm 1412. Pivot arm 1412 is attached to patient fixation instrument 1402 by inserting patient fixation instrument 1402 through an opening 1414 of registration fixture 1410. Pivot arm 1412 is attached to registration fixture 1410 by, for example, inserting a knob 1416 through an opening 1418 of pivot arm 1412.
Using pivot arm 1412, registration fixture 1410 may be placed over the targeted anatomical structure and its location may be determined in an image space and navigation space using tracking markers 1420 and/or fiducials 1422 on registration fixture 1410. Registration fixture 1410 may contain a collection of markers 1420 that are visible in a navigational space (for example, markers 1420 may be detectable by tracking subsystem 532). Tracking markers 1420 may be optical markers visible in infrared light as previously described herein. Registration fixture 1410 may also contain a collection of fiducials 1422, for example, such as bearing balls, that are visible in an imaging space (for example, a three dimension CT image). As described in greater detail with respect to
At step 1504, an imaging pattern of fiducials 1420 is detected and registered in the imaging space and stored in computer 408. Optionally, at this time at step 1506, a graphical representation of the registration fixture 1410 may be overlaid on the images of the targeted anatomical structure.
At step 1508, a navigational pattern of registration fixture 1410 is detected and registered by recognizing markers 1420. Markers 1420 may be optical markers that are recognized in the navigation space through infrared light by tracking subsystem 532 via position sensor 540. Thus, the location, orientation, and other information of the targeted anatomical structure is registered in the navigation space. Therefore, registration fixture 1410 may be recognized in both the image space through the use of fiducials 1422 and the navigation space through the use of markers 1420. At step 1510, the registration of registration fixture 1410 in the image space is transferred to the navigation space. This transferal is done, for example, by using the relative position of the imaging pattern of fiducials 1422 compared to the position of the navigation pattern of markers 1420.
At step 1512, registration of the navigation space of registration fixture 1410 (having been registered with the image space) is further transferred to the navigation space of dynamic registration array 1404 attached to patient fixture instrument 1402. Thus, registration fixture 1410 may be removed and dynamic reference base 1404 may be used to track the targeted anatomical structure in both the navigation and image space because the navigation space is associated with the image space.
At steps 1514 and 1516, the navigation space may be overlaid on the image space and objects with markers visible in the navigation space (for example, surgical instruments 608 with optical markers 804). The objects may be tracked through graphical representations of the surgical instrument 608 on the images of the targeted anatomical structure.
Turning now to
When tracking an instrument 608, end-effector 112, or other object to be tracked in 3D, an array of tracking markers 118, 804 may be rigidly attached to a portion of the tool 608 or end-effector 112. Preferably, the tracking markers 118, 804 are attached such that the markers 118, 804 are out of the way (e.g., not impeding the surgical operation, visibility, etc.). The markers 118, 804 may be affixed to the instrument 608, end-effector 112, or other object to be tracked, for example, with an array 612. Usually three or four markers 118, 804 are used with an array 612. The array 612 may include a linear section, a cross piece, and may be asymmetric such that the markers 118, 804 are at different relative positions and locations with respect to one another. For example, as shown in
In
To enable automatic tracking of one or more tools 608, end-effector 112, or other object to be tracked in 3D (e.g., multiple rigid bodies), the markers 118, 804 on each tool 608, end-effector 112, or the like, are arranged asymmetrically with a known inter-marker spacing. The reason for asymmetric alignment is so that it is unambiguous which marker 118, 804 corresponds to a particular location on the rigid body and whether markers 118, 804 are being viewed from the front or back, i.e., mirrored. For example, if the markers 118, 804 were arranged in a square on the tool 608 or end-effector 112, it would be unclear to the system 100, 300, 600 which marker 118, 804 corresponded to which corner of the square. For example, for the probe 608A, it would be unclear which marker 804 was closest to the shaft 622. Thus, it would be unknown which way the shaft 622 was extending from the array 612. Accordingly, each array 612 and thus each tool 608, end-effector 112, or other object to be tracked should have a unique marker pattern to allow it to be distinguished from other tools 608 or other objects being tracked. Asymmetry and unique marker patterns allow the system 100, 300, 600 to detect individual markers 118, 804 then to check the marker spacing against a stored template to determine which tool 608, end effector 112, or other object they represent. Detected markers 118, 804 can then be sorted automatically and assigned to each tracked object in the correct order. Without this information, rigid body calculations could not then be performed to extract key geometric information, for example, such as tool tip 624 and alignment of the shaft 622, unless the user manually specified which detected marker 118, 804 corresponded to which position on each rigid body. These concepts are commonly known to those skilled in the methods of 3D optical tracking.
Turning now to
In this embodiment, 4-marker array tracking is contemplated wherein the markers 918A-918D are not all in fixed position relative to the rigid body and instead, one or more of the array markers 918A-918D can be adjusted, for example, during testing, to give updated information about the rigid body that is being tracked without disrupting the process for automatic detection and sorting of the tracked markers 918A-918D.
When tracking any tool, such as a guide tube 914 connected to the end effector 912 of a robot system 100, 300, 600, the tracking array's primary purpose is to update the position of the end effector 912 in the camera coordinate system. When using the rigid system, for example, as shown in
Sometimes, the desired trajectory is in an awkward or unreachable location, but if the guide tube 114 could be swiveled, it could be reached. For example, a very steep trajectory pointing away from the base 106 of the robot 102 might be reachable if the guide tube 114 could be swiveled upward beyond the limit of the pitch (wrist up-down angle) axis, but might not be reachable if the guide tube 114 is attached parallel to the plate connecting it to the end of the wrist. To reach such a trajectory, the base 106 of the robot 102 might be moved or a different end effector 112 with a different guide tube attachment might be exchanged with the working end effector. Both of these solutions may be time consuming and cumbersome.
As best seen in
In the embodiment shown in
The guide tube 914 may be moveable, swivelable, or pivotable relative to the base 906, for example, across a hinge 920 or other connector to the base 906. Thus, markers 918C, 918D are moveable such that when the guide tube 914 pivots, swivels, or moves, markers 918C, 918D also pivot, swivel, or move. As best seen in
In contrast to the embodiment described for
One or more of the markers 918A-918D are configured to be moved, pivoted, swiveled, or the like according to any suitable means. For example, the markers 918A-918D may be moved by a hinge 920, such as a clamp, spring, lever, slide, toggle, or the like, or any other suitable mechanism for moving the markers 918A-918D individually or in combination, moving the arrays 908A, 908B individually or in combination, moving any portion of the end-effector 912 relative to another portion, or moving any portion of the tool 608 relative to another portion.
As shown in
The cameras 200, 326 detect the markers 918A-918D, for example, in one of the templates identified in
In this embodiment, there are two assembly positions in which the marker array matches unique templates that allow the system 100, 300, 600 to recognize the assembly as two different tools or two different end effectors. In any position of the swivel between or outside of these two positions (namely, Array Template 1 and Array Template 2 shown in
In the embodiment described, two discrete assembly positions are shown in
When using an external 3D tracking system 100, 300, 600 to track a full rigid body array of three or more markers attached to a robot's end effector 112 (for example, as depicted in
In some situations, it may be desirable to track the positions of all segments of the robot 102 from fewer than three markers 118 rigidly attached to the end effector 112. Specifically, if a tool 608 is introduced into the guide tube 114, it may be desirable to track full rigid body motion of the robot 902 with only one additional marker 118 being tracked.
Turning now to
The single tracking marker 1018 may be attached to the robotic end effector 1012 as a rigid extension to the end effector 1012 that protrudes in any convenient direction and does not obstruct the surgeon's view. The tracking marker 1018 may be affixed to the guide tube 1014 or any other suitable location of on the end-effector 1012. When affixed to the guide tube 1014, the tracking marker 1018 may be positioned at a location between first and second ends of the guide tube 1014. For example, in
As shown in
Referring now to
The fixed normal (perpendicular) distance DF from the single marker 1018 to the centerline or longitudinal axis 1016 of the guide tube 1014 is fixed and is known geometrically, and the position of the single marker 1018 can be tracked. Therefore, when a detected distance DD from tool centerline 616 to single marker 1018 matches the known fixed distance DF from the guide tube centerline 1016 to the single marker 1018, it can be determined that the tool 608 is either within the guide tube 1014 (centerlines 616, 1016 of tool 608 and guide tube 1014 coincident) or happens to be at some point in the locus of possible positions where this distance DD matches the fixed distance Dr. For example, in
Turning now to
Logistically, the surgeon 120 or user could place the tool 608 within the guide tube 1014 and slightly rotate it or slide it down into the guide tube 1014 and the system 100, 300, 600 would be able to detect that the tool 608 is within the guide tube 1014 from tracking of the five markers (four markers 804 on tool 608 plus single marker 1018 on guide tube 1014). Knowing that the tool 608 is within the guide tube 1014, all 6 degrees of freedom may be calculated that define the position and orientation of the robotic end effector 1012 in space. Without the single marker 1018, even if it is known with certainty that the tool 608 is within the guide tube 1014, it is unknown where the guide tube 1014 is located along the tool's centerline vector C′ and how the guide tube 1014 is rotated relative to the centerline vector C′.
With emphasis on
In some embodiments, it may be useful to fix the orientation of the tool 608 relative to the guide tube 1014. For example, the end effector guide tube 1014 may be oriented in a particular position about its axis 1016 to allow machining or implant positioning. Although the orientation of anything attached to the tool 608 inserted into the guide tube 1014 is known from the tracked markers 804 on the tool 608, the rotational orientation of the guide tube 1014 itself in the camera coordinate system is unknown without the additional tracking marker 1018 (or multiple tracking markers in other embodiments) on the guide tube 1014. This marker 1018 provides essentially a “clock position” from −180° to +180° based on the orientation of the marker 1018 relative to the centerline vector C′. Thus, the single marker 1018 can provide additional degrees of freedom to allow full rigid body tracking and/or can act as a surveillance marker to ensure that assumptions about the robot and camera positioning are valid.
For this method 1100, the coordinate systems of the tracker and the robot must be co-registered, meaning that the coordinate transformation from the tracking system's Cartesian coordinate system to the robot's Cartesian coordinate system is needed. For convenience, this coordinate transformation can be a 4×4 matrix of translations and rotations that is well known in the field of robotics. This transformation will be termed Tcr to refer to “transformation—camera to robot”. Once this transformation is known, any new frame of tracking data, which is received as x,y,z coordinates in vector form for each tracked marker, can be multiplied by the 4×4 matrix and the resulting x,y,z coordinates will be in the robot's coordinate system. To obtain Tcr, a full tracking array on the robot is tracked while it is rigidly attached to the robot at a location that is known in the robot's coordinate system, then known rigid body methods are used to calculate the transformation of coordinates. It should be evident that any tool 608 inserted into the guide tube 1014 of the robot 102 can provide the same rigid body information as a rigidly attached array when the additional marker 1018 is also read. That is, the tool 608 need only be inserted to any position within the guide tube 1014 and at any rotation within the guide tube 1014, not to a fixed position and orientation. Thus, it is possible to determine Tcr by inserting any tool 608 with a tracking array 612 into the guide tube 1014 and reading the tool's array 612 plus the single marker 1018 of the guide tube 1014 while at the same time determining from the encoders on each axis the current location of the guide tube 1014 in the robot's coordinate system.
Logic for navigating and moving the robot 102 to a target trajectory is provided in the method 1100 of
In the flowchart of method 1100, each frame of data collected consists of the tracked position of the DRB 1404 on the patient 210, the tracked position of the single marker 1018 on the end effector 1014, and a snapshot of the positions of each robotic axis. From the positions of the robot's axes, the location of the single marker 1018 on the end effector 1012 is calculated. This calculated position is compared to the actual position of the marker 1018 as recorded from the tracking system. If the values agree, it can be assured that the robot 102 is in a known location. The transformation Tcr is applied to the tracked position of the DRB 1404 so that the target for the robot 102 can be provided in terms of the robot's coordinate system. The robot 102 can then be commanded to move to reach the target.
After steps 1104, 1106, loop 1102 includes step 1108 receiving rigid body information for DRB 1404 from the tracking system; step 1110 transforming target tip and trajectory from image coordinates to tracking system coordinates; and step 1112 transforming target tip and trajectory from camera coordinates to robot coordinates (apply Tcr). Loop 1102 further includes step 1114 receiving a single stray marker position for robot from tracking system; and step 1116 transforming the single stray marker from tracking system coordinates to robot coordinates (apply stored Tcr). Loop 1102 also includes step 1118 determining current location of the single robot marker 1018 in the robot coordinate system from forward kinematics. The information from steps 1116 and 1118 is used to determine step 1120 whether the stray marker coordinates from transformed tracked position agree with the calculated coordinates being less than a given tolerance. If yes, proceed to step 1122, calculate and apply robot move to target x, y, z and trajectory. If no, proceed to step 1124, halt and require full array insertion into guide tube 1014 before proceeding; step 1126 after array is inserted, recalculate Tcr; and then proceed to repeat steps 1108, 1114, and 1118.
This method 1100 has advantages over a method in which the continuous monitoring of the single marker 1018 to verify the location is omitted. Without the single marker 1018, it would still be possible to determine the position of the end effector 1012 using Tcr and to send the end-effector 1012 to a target location but it would not be possible to verify that the robot 102 was actually in the expected location. For example, if the cameras 200, 326 had been bumped and Tcr was no longer valid, the robot 102 would move to an erroneous location. For this reason, the single marker 1018 provides value with regard to safety.
For a given fixed position of the robot 102, it is theoretically possible to move the tracking cameras 200, 326 to a new location in which the single tracked marker 1018 remains unmoved since it is a single point, not an array. In such a case, the system 100, 300, 600 would not detect any error since there would be agreement in the calculated and tracked locations of the single marker 1018. However, once the robot's axes caused the guide tube 1012 to move to a new location, the calculated and tracked positions would disagree and the safety check would be effective.
The term “surveillance marker” may be used, for example, in reference to a single marker that is in a fixed location relative to the DRB 1404. In this instance, if the DRB 1404 is bumped or otherwise dislodged, the relative location of the surveillance marker changes and the surgeon 120 can be alerted that there may be a problem with navigation. Similarly, in the embodiments described herein, with a single marker 1018 on the robot's guide tube 1014, the system 100, 300, 600 can continuously check whether the cameras 200, 326 have moved relative to the robot 102. If registration of the tracking system's coordinate system to the robot's coordinate system is lost, such as by cameras 200, 326 being bumped or malfunctioning or by the robot malfunctioning, the system 100, 300, 600 can alert the user and corrections can be made. Thus, this single marker 1018 can also be thought of as a surveillance marker for the robot 102.
It should be clear that with a full array permanently mounted on the robot 102 (e.g., the plurality of tracking markers 702 on end-effector 602 shown in
Turning now to
When tracking the tool 608, such as implant holder 608B, 608C, the tracking array 612 may contain a combination of fixed markers 804 and one or more moveable markers 806 which make up the array 612 or is otherwise attached to the implant holder 608B, 608C. The navigation array 612 may include at least one or more (e.g., at least two) fixed position markers 804, which are positioned with a known location relative to the implant holder instrument 608B, 608C. These fixed markers 804 would not be able to move in any orientation relative to the instrument geometry and would be useful in defining where the instrument 608 is in space. In addition, at least one marker 806 is present which can be attached to the array 612 or the instrument itself which is capable of moving within a pre-determined boundary (e.g., sliding, rotating, etc.) relative to the fixed markers 804. The system 100, 300, 600 (e.g., the software) correlates the position of the moveable marker 806 to a particular position, orientation, or other attribute of the implant 10 (such as height of an expandable interbody spacer shown in
In the embodiment shown in
Turning now to
In these embodiments, the moveable marker 806 slides continuously to provide feedback about an attribute of the implant 10, 12 based on position. It is also contemplated that there may be discreet positions that the moveable marker 806 must be in which would also be able to provide further information about an implant attribute. In this case, each discreet configuration of all markers 804, 806 correlates to a specific geometry of the implant holder 608B, 608C and the implant 10, 12 in a specific orientation or at a specific height. In addition, any motion of the moveable marker 806 could be used for other variable attributes of any other type of navigated implant.
Although depicted and described with respect to linear movement of the moveable marker 806, the moveable marker 806 should not be limited to just sliding as there may be applications where rotation of the marker 806 or other movements could be useful to provide information about the implant 10, 12. Any relative change in position between the set of fixed markers 804 and the moveable marker 806 could be relevant information for the implant 10, 12 or other device. In addition, although expandable and articulating implants 10, 12 are exemplified, the instrument 608 could work with other medical devices and materials, such as spacers, cages, plates, fasteners, nails, screws, rods, pins, wire structures, sutures, anchor clips, staples, stents, bone grafts, biologics, cements, or the like.
Turning now to
The alternative end-effector 112 may include one or more devices or instruments coupled to and controllable by the robot. By way of non-limiting example, the end-effector 112, as depicted in
The end-effector itself and/or the implant, device, or instrument may include one or more markers 118 such that the location and position of the markers 118 may be identified in three-dimensions. It is contemplated that the markers 118 may include active or passive markers 118, as described herein, that may be directly or indirectly visible to the cameras 200. Thus, one or more markers 118 located on an implant 10, for example, may provide for tracking of the implant 10 before, during, and after implantation.
As shown in
Although the robot and associated systems described above are generally described with reference to spine applications, it is also contemplated that the robot system is configured for use in other surgical applications, including but not limited to, surgeries in trauma or other orthopedic applications (such as the placement of intramedullary nails, plates, and the like), cranial, neuro, cardiothoracic, vascular, colorectal, oncological, dental, and other surgical operations and procedures. According to some embodiments discussed below, robot systems may be used for brain surgery applications.
As discussed herein, operations of controlling a robotic system according to some embodiments of the present disclosure may be performed by controller 2000 including processor 2007, input interface 2001, output interface 2003, and/or control interface 2005. For example, processor 2007 may receive user input through input interface 2001, and such user input may include user input received through foot pedal 544, tablet 546, a touch sensitive interface of display 110/304, etc. Processor 2007 may also receive position sensor input from tracking subsystem 532 and/or cameras 200 through input interface 2001. Processor 2007 may provide output through output interface 2003, and such out may include information to render graphic/visual information on display 110/304 and/or audio output to be provided through speaker 536. Processor 2007 may provide robotic control information through control interface 2005 to motion control subsystem 506, and the robotic control information may be used to control operation of a robotic actuator (such as robot arm 104/306-308/604, also referred to as a robotic arm), and/or end-effector 112/602.
A fiducial (also referred to as a fiducial point or a fiducial object) is a point on an object (in 3-dimensional 3D space) that can be localized in the 3D coordinate system of the image scan (e.g., a preoperative MRI scan and an intraoperative CT scan). It is often possible to detect the same fiducial within two or more different image scans. If at least three fiducials are located in two different coordinate systems, the two coordinate systems can be co-registered using the three or more fiducials. Once two coordinate systems for respective 3D image scans have been co-registered, a known point or object (e.g., a location of a tumor) in one of the image scans can be identified/located in the other image scan. If a tumor is located/identified in a preoperative MRI scan, for example, a coordinate system of the preoperative MRI scan can be co-registered with a coordinate system of an intraoperative CT scan to allow localization of the tumor in the intraoperative CT scan. In a surgical robotic system, it may be easier and more accurate to register the tracking camera's coordinate system to an intraoperative CT scan volume (e.g., using the registration method of
An artificial fiducial may be provided using an artificial object that is placed or adhered to/near the anatomical object of interest, and the artificial fiducial may be a sphere, a donut, or a divot that has features allowing it to be accurately and repeatably identified. For example, an artificial fiducial could be a metallic bb that is adhered to an object to be tracked. The metallic bb can be detected by processor 2007 using image processing techniques within a 3D scan to provide its 3D position in the coordinate system of the scan, and/or the metallic bb can be detected by touching the surface of the sphere with a tracked probe to provide its 3D position in a coordinate system of a robotic system (e.g., using optical tracking cameras 200/326).
According to some embodiments of inventive concepts, when performing cranial surgery, distinctive anatomical features on/in the brain may serve as natural fiducials. Particularly, the brain's naturally occurring blood vessels may serve as natural fiducial points rather than (or in addition to) inserting or placing an artificial fiducial object(s) in/on the brain/head/skull. Since blood vessels traverse and branch in unique patterns, the vessels in their entirety can serve as fiducial objects. However, with swelling, shrinking and shifting of the brain, it may be more difficult to keep track of the distortion of entire vessels than to follow displacement of any node (also referred to as a point) where a blood vessel (e.g., an artery or a vein) branches. These nodes (points) may be detected by processor 2007 using image processing in a preoperative scan/scans (e.g., a Magnetic Resonance Imaging MRI scan or a Computed Tomography CT scan), an intraoperative scan/scans (e.g., an MRI scan or CT scan), x-rays, and/or ultrasound. Branch nodes (points) of blood vessels (also referred to as blood vessel nodes) may provide unique natural fiducials because such blood vessel nodes provide good coverage permeating most/all regions of the brain. When used as a group, branch nodes of blood vessels may thus be used by processor 2007 to accurately monitor shifting/distortion of different regions of the brain and/or the whole brain. Moreover, various ones of the blood vessel nodes may be distinct in shape, direction, and distance from adjacent branch nodes, allowing such branch nodes to be automatically detected/identified and sorted in different 3D scans of the brain.
In order for processor 2007 to co-register two or more different coordinate systems, it may be useful/necessary to locate a plurality of (e.g., at least three) natural and/or artificial fiducials in the image scans for which coordinate systems are to be co-registered, and automatic identification of the locations of the fiducials in the scans may be preferred to manual identification of the locations. When using 3D image volumes (e.g., MRI or CT scans), automated image processing algorithms may be used by processor 2007 to auto-detect branch points on blood vessels using different components for detection/identification of blood vessel nodes.
One component of such automated image processing algorithms may include processor 2007 determining a direction in which the branch is occurring. When looking at blood vessel branches extending in different directions, the trunk blood vessel and the branch blood vessels for the node may be determined to identify a direction of the branch. For example, processor 2007 may use image processing to follow a blood vessel until it reaches a node (also referred to as a branch or branch point) where it meets with two or more other blood vessels. At the node, sizes (e.g., diameters and/or cross-sections) of the blood vessels may be assessed by processor 2007. The blood vessel at the node with the largest size (e.g., diameter and/or cross-section) can be identified as the trunk blood vessel for the node, and the other blood vessels at the node (with smaller sizes) can be identified as branch blood vessels for the node. This information may be useful for processor 2007 to categorize, identify, and/or locate the blood vessel nodes, and to identify/locate the same blood vessel nodes as natural fiducials in different scans of the same anatomical volume.
Another component of such automated image processing algorithms may include processor 2007 determining distances between blood vessel nodes/branches. When following a blood vessel along its course, distances from one node/branch to the next are not likely to be identical. The distances between consecutive nodes/branches (along a path of blood vessels) can thus be measured and used to identify particular blood vessels and/or nodes/branches thereof. The different distances between nodes/branches can thus be used to identify particular blood vessels and nodes/branches that those blood vessels pass through, and this information can be used by processor 2007 to identify/locate the same nodes/branches in a different scan of the same anatomical volume. This information, for example, can be used to generate a map of internode distances along blood vessel pathways through the brain, and the map of internode distances can be used to identify the same blood vessel nodes as natural fiducials in different scans of the same anatomical volume.
According to some embodiments of inventive concepts, processor 2007 may thus detect blood vessel nodes in a CT scan (with contrast) and/or in an MRI scan. Processor 2007 may find a candidate blood vessel by identifying a structure appearing as a high-contrast thin snaking line through lower intensity surrounding tissues. The blood vessel may be followed in one direction until a node with two (or more) new branches is encountered. Based on comparing sizes (e.g., cross-sections and/or diameters) of blood vessels at the node, processor 2007 may determine whether the blood vessel being followed is being followed up or down the tree structure. If being followed down (to smaller sized branches), the direction may be reversed, and the blood vessel may be followed in the opposite direction up its tree structure. Once processor 2007 detects the node representing the first branch point of the trunk blood vessel, the trunk blood vessel may be followed down to the next blood vessel node where two or more smaller blood vessels branch from the trunk blood vessel. In this manner, processor 2007 can map and identify blood vessel nodes throughout the brain.
In the example of
When mapping blood vessel branches defining nodes to be used as natural fiducials, processor 2007 may use other factors to uniquely define/identify the blood vessel branches and/or nodes. According to some embodiments, a shape of a trunk and/or branch blood vessel of a node may be used to identify the node. For example, a blood vessel may define a squiggly line or a blood vessel may turn sharply in one direction and then turn sharply in another direction after a short distance. These shape features may be useful for processor 2007 to identify/verify a particular trunk/branch blood vessel that is being followed and/or node associated with the trunk/branch blood vessel. Such information may be especially useful if inter-node distances are ambiguous in distinguishing between blood vessels. According to some other embodiments, inter-branch angles between two smaller branches at a node may be used to define/identify a node. For example, an angle between branches A and B at node AB may be used to identify/define node AB.
Operations discussed above with respect to
Operations discussed above may be used by processor 2007 to co-register coordinate systems of two medical 3D image scans. To control robotic operations based on information from such 3D image scans, registration to a tracking coordinate system used by the robot may also be performed. Such a tracking coordinate system may be based on optical information received by processor 2007 from cameras 200/326 through input interface 2001. For such registration, external markers may be attached to the patient. For example, an external ICT (intraoperative CT) frame may contain metal fiducials 1422 and optical tracking markers 1420 in fixed positions relative to each other. By capturing the metal fiducials in the same scan as the natural fiducials and their respective locations determined by processor 2007 using image processing, relative positions of the metal fiducials, optical tracking markers, and blood vessel nodes may be determined and used to provide co-registration of the coordinate system of the robot with the coordinate system of intraoperative CT scan. Processor 2007 can then control the robotic actuator (e.g., robot arm 104/604) to manipulate tracked tools in relation to the anatomy of the intraoperative CT scan and/or another scan (e.g., preoperative MRI scan) with a coordinate system that has been co-registered with respect to the ICT scan.
The ICT scan may not be captured within a preoperative scan on which surgical planning is performed (e.g., a high-resolution MRI scan). In the preoperative scan, natural fiducials (e.g., blood vessel nodes) may be detected and their positions recorded, and the preoperative scan may be provided to processor 2007 with information regarding a planned trajectory for an end-effector 112/602 of the robotic actuator. The ICT fiducials (artificial fiducials) may be attached to the patient and captured in the ICT scan (e.g., a CT scan using dye contrast), and tracking registration would be established by processor 2007 relative to the ICT fiducials and new natural fiducials. By detecting and relating the new natural fiducials in the ICT scan to the original natural fiducials in the preoperative MRI scan, all plans of trajectories into the brain that were made relative to the preoperative MRI scan may be automatically related to the intraoperative CT scan and to the optical tracking system. Such co-registration may compensate for shifting/distortion of the brain (or portions thereof) that may occur during surgery after planning trajectories using a preoperative image scan. This registration using blood vessel nodes as fiducials may be more accurate than registration of CT to MRI based on skull structures because the brain may shift relative to such skull structures in the preoperative and intraoperative scans.
In addition, the brain may shrink or swell during surgery and/or from the time of the preoperative scan to the intraoperative scan. When matching blood vessel nodes in the preoperative and intraoperative scans, processor 2007 may perform an affine transformation for a best fit of blood vessel nodes to account for non-rigid-body movement of the blood vessel nodes that would be expected as the brain expands or shrinks. Processor 2007 may analyze parameters used by the affine transformation to achieve a fit to provide an estimate of an amount by which different regions of the brain swell or shrink during surgery. Such information may be useful in research to track outcomes of brain surgery.
According to some other embodiments, ultrasound may be used to generate an image scan used to detect blood vessel nodes to be used as fiducials and relate the blood vessel nodes to the tracking coordinate system of the robot. Using ultrasound with a tracked probe (i.e., a probe that is tracked by the optical tracking system of the robot), locations of blood vessel nodes may be triangulated through different probe poses or by simultaneously tracking the same node with two probes at different angles. According to some embodiments using ultrasound, the Doppler effect may be used to guide the probe to find blood vessels and to determine which way the blood is flowing since blood flowing through blood vessels creates a different signal on ultrasound than static tissues due to the Doppler effect.
By using natural fiducials such as blood vessel nodes within the brain itself, tracking may be more accurate than if only external fiducials are used to co-register the different coordinate systems. Moreover, use of blood vessel nodes may provide detection of and/or accommodation for swelling, shrinking, and/or other non-uniform shifting/distortion from a preoperative scan to an intraoperative scan. In addition, comparison of blood vessel nodes may be used to provide real time monitoring of brain shifts, swelling, shrinking, and/or distortion.
Operations of a robotic system (including a robotic actuator configured to position an end-effector with respect to an anatomical location of a patient) will now be discussed with reference to the flow chart of
At block 2301, processor 2007 may provide first data for a first 3-dimensional (3D) image scan of an anatomical volume (e.g., the patient's head, including the brain), and the first data may identify first, second, and third blood vessel nodes (to be used as natural fiducials) in a first coordinate system for the first 3D image scan. The first 3D image scan, for example, may be a preoperative MRI scan, and a planned trajectory for a robotic actuator may be provided with the first 3D image scan. The planned trajectory, for example, may define a target location in the anatomical volume and a direction to the target location. The identification of the first, second, and third blood vessel nodes may be provided to processor 2007 with the first 3D image scan, or processor 2007 may use image processing to identify the first, second, and third blood vessel nodes from the first 3D image scan.
At block 2303, processor 2007 may provide second data for a second 3D image scan of the anatomical volume, and the second data may identify the first, second, and third blood vessel nodes in a second coordinate system for the second 3D image scan. The second 3D image scan, for example, may be an intraoperative CT scan, and the second data for the second 3D image scan may also identify an artificial fiducial outside the anatomical volume that can be separately tracked using cameras 200/326. Processor 2007, for example, may identify the first, second, and third blood vessel nodes in the first and/or second 3D image scans as discussed above with respect to
At block 2305, processor 2007 may co-register the first and second coordinate systems for the first and second 3D image scans of the anatomical volume using the first, second, and third blood vessel nodes identified in the first data and in the second data as first, second, and third natural fiducials. Because the blood vessel nodes move with the brain, the use of blood vessel nodes may provide increased accuracy for co-registration even if shifting, shrinking, swelling, and/or deformation occur between image scans. By co-registering the first and second coordinate systems, processor 2007 may be able to translate additional information, e.g., the target location and/or planned trajectory for the robotic actuator, from the first 3D image scan to the second 3D image scan.
At block 2307, processor may co-register the second coordinate system for the second 3D image scan and a third coordinate system for the robotic actuator using the artificial fiducial from the second 3D image scan. Because the artificial fiducial can be tracked using cameras 200/326 and/or tracking system 532, co-registering the second and third coordinate systems may be performed using optical information from tracking cameras 200/326 to locate the artificial fiducial in the third coordinate system for the robotic actuator.
At block 2309, processor 2007 may provide the target location in one of the second and third coordinate systems using a transformation based on the first, second, and third blood vessel nodes in the first and second coordinate systems. The transformation, for example, may include an affine transformation. Such a transformation may provide a more accurate location of the target location for the robotic actuator to accommodate for shifting, shrinking, swelling, and/or other deformation of the brain between the first and second 3D image scans.
At block 2311, processor 2007 may control the robotic actuator (e.g., robotic arm 104/306-308/604) to move the end-effector 112/302/602 to a target trajectory relative to the anatomical volume and target location therein. Processor 2007, for example, may control the robotic actuator based on one or more of: the first data identifying the target location; co-registering the first and second coordinate systems; based on co-registering the second and third coordinate systems; and/or providing the target location in one of the second and third coordinate systems using the transformation.
According to some embodiments of
In the above-description of various embodiments of present inventive concepts, it is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of present inventive concepts. Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which present inventive concepts belong. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of this specification and the relevant art and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
When an element is referred to as being “connected”, “coupled”, “responsive”, or variants thereof to another element, it can be directly connected, coupled, or responsive to the other element or intervening elements may be present. In contrast, when an element is referred to as being “directly connected”, “directly coupled”, “directly responsive”, or variants thereof to another element, there are no intervening elements present. Like numbers refer to like elements throughout. Furthermore, “coupled”, “connected”, “responsive”, or variants thereof as used herein may include wirelessly coupled, connected, or responsive. As used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. Well-known functions or constructions may not be described in detail for brevity and/or clarity. The term “and/or” includes any and all combinations of one or more of the associated listed items.
It will be understood that although the terms first, second, third, etc. may be used herein to describe various elements/operations, these elements/operations should not be limited by these terms. These terms are only used to distinguish one element/operation from another element/operation. Thus, a first element/operation in some embodiments could be termed a second element/operation in other embodiments without departing from the teachings of present inventive concepts. The same reference numerals or the same reference designators denote the same or similar elements throughout the specification.
As used herein, the terms “comprise”, “comprising”, “comprises”, “include”, “including”, “includes”, “have”, “has”, “having”, or variants thereof are open-ended, and include one or more stated features, integers, elements, steps, components or functions but does not preclude the presence or addition of one or more other features, integers, elements, steps, components, functions or groups thereof. Furthermore, as used herein, the common abbreviation “e.g.”, which derives from the Latin phrase “exempli gratia,” may be used to introduce or specify a general example or examples of a previously mentioned item, and is not intended to be limiting of such item. The common abbreviation “i.e.”, which derives from the Latin phrase “id est,” may be used to specify a particular item from a more general recitation.
Example embodiments are described herein with reference to block diagrams and/or flowchart illustrations of computer-implemented methods, apparatus (systems and/or devices) and/or computer program products. It is understood that a block of the block diagrams and/or flowchart illustrations, and combinations of blocks in the block diagrams and/or flowchart illustrations, can be implemented by computer program instructions that are performed by one or more computer circuits. These computer program instructions may be provided to a processor circuit of a general purpose computer circuit, special purpose computer circuit, and/or other programmable data processing circuit to produce a machine, such that the instructions, which execute via the processor of the computer and/or other programmable data processing apparatus, transform and control transistors, values stored in memory locations, and other hardware components within such circuitry to implement the functions/acts specified in the block diagrams and/or flowchart block or blocks, and thereby create means (functionality) and/or structure for implementing the functions/acts specified in the block diagrams and/or flowchart block(s).
These computer program instructions may also be stored in a tangible computer-readable medium that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable medium produce an article of manufacture including instructions which implement the functions/acts specified in the block diagrams and/or flowchart block or blocks. Accordingly, embodiments of present inventive concepts may be embodied in hardware and/or in software (including firmware, resident software, micro-code, etc.) that runs on a processor such as a digital signal processor, which may collectively be referred to as “circuitry,” “a module” or variants thereof.
It should also be noted that in some alternate implementations, the functions/acts noted in the blocks may occur out of the order noted in the flowcharts. For example, two blocks shown in succession may in fact be executed substantially concurrently or the blocks may sometimes be executed in the reverse order, depending upon the functionality/acts involved. Moreover, the functionality of a given block of the flowcharts and/or block diagrams may be separated into multiple blocks and/or the functionality of two or more blocks of the flowcharts and/or block diagrams may be at least partially integrated. Finally, other blocks may be added/inserted between the blocks that are illustrated, and/or blocks/operations may be omitted without departing from the scope of inventive concepts. Moreover, although some of the diagrams include arrows on communication paths to show a primary direction of communication, it is to be understood that communication may occur in the opposite direction to the depicted arrows.
Although several embodiments of inventive concepts have been disclosed in the foregoing specification, it is understood that many modifications and other embodiments of inventive concepts will come to mind to which inventive concepts pertain, having the benefit of teachings presented in the foregoing description and associated drawings. It is thus understood that inventive concepts are not limited to the specific embodiments disclosed hereinabove, and that many modifications and other embodiments are intended to be included within the scope of the appended claims. It is further envisioned that features from one embodiment may be combined or used with the features from a different embodiment(s) described herein. Moreover, although specific terms are employed herein, as well as in the claims which follow, they are used only in a generic and descriptive sense, and not for the purposes of limiting the described inventive concepts, nor the claims which follow. The entire disclosure of each patent and patent publication cited herein is incorporated by reference herein in its entirety, as if each such patent or publication were individually incorporated by reference herein. Various features and/or potential advantages of inventive concepts are set forth in the following claims.
The present application is a non-provisional patent application that claims priority to provisional application 62/634,245 filed on Feb. 23, 2018. This present application is also a continuation-in-part application of U.S. patent application Ser. No. 15/609,334 filed on May 31, 2017, which is continuation-in-part of U.S. patent application Ser. No. 15/157,444, filed May 18, 2016, which is a continuation-in-part of U.S. patent application Ser. No. 15/095,883, filed Apr. 11, 2016, which is a continuation-in-part of U.S. patent application Ser. No. 14/062,707, filed on Oct. 24, 2013, which is a continuation-in-part application of U.S. patent application Ser. No. 13/924,505, filed on Jun. 21, 2013, which claims priority to provisional application No. 61/662,702 filed on Jun. 21, 2012 and claims priority to provisional application No. 61/800,527 filed on Mar. 15, 2013, all of which are incorporated by reference herein in their entireties for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
4150293 | Franke | Apr 1979 | A |
5020933 | Salvestro et al. | Jun 1991 | A |
5246010 | Gazzara et al. | Sep 1993 | A |
5354314 | Hardy et al. | Oct 1994 | A |
5397323 | Taylor et al. | Mar 1995 | A |
5598453 | Baba et al. | Jan 1997 | A |
5772594 | Barrick | Jun 1998 | A |
5791908 | Gillio | Aug 1998 | A |
5820559 | Ng et al. | Oct 1998 | A |
5825982 | Wright et al. | Oct 1998 | A |
5887121 | Funda et al. | Mar 1999 | A |
5911449 | Daniele et al. | Jun 1999 | A |
5951475 | Gueziec et al. | Sep 1999 | A |
5987960 | Messner et al. | Nov 1999 | A |
6012216 | Esteves et al. | Jan 2000 | A |
6031888 | Ivan et al. | Feb 2000 | A |
6033415 | Mittelstadt et al. | Mar 2000 | A |
6080181 | Jensen et al. | Jun 2000 | A |
6106511 | Jensen | Aug 2000 | A |
6122541 | Cosman et al. | Sep 2000 | A |
6144875 | Schweikard et al. | Nov 2000 | A |
6157853 | Blume et al. | Dec 2000 | A |
6167145 | Foley et al. | Dec 2000 | A |
6167292 | Badano et al. | Dec 2000 | A |
6201984 | Funda et al. | Mar 2001 | B1 |
6203196 | Meyer et al. | Mar 2001 | B1 |
6205411 | DiGioia, III et al. | Mar 2001 | B1 |
6212419 | Blume et al. | Apr 2001 | B1 |
6231565 | Tovey et al. | May 2001 | B1 |
6236875 | Bucholz et al. | May 2001 | B1 |
6246900 | Cosman et al. | Jun 2001 | B1 |
6301495 | Gueziec et al. | Oct 2001 | B1 |
6306126 | Montezuma | Oct 2001 | B1 |
6312435 | Wallace et al. | Nov 2001 | B1 |
6314311 | Williams et al. | Nov 2001 | B1 |
6320929 | Von Der Haar | Nov 2001 | B1 |
6322567 | Mittelstadt et al. | Nov 2001 | B1 |
6325808 | Bernard et al. | Dec 2001 | B1 |
6340363 | Bolger et al. | Jan 2002 | B1 |
6377011 | Ben-Ur | Apr 2002 | B1 |
6379302 | Kessman et al. | Apr 2002 | B1 |
6402762 | Hunter et al. | Jun 2002 | B2 |
6424885 | Niemeyer et al. | Jul 2002 | B1 |
6447503 | Wynne et al. | Sep 2002 | B1 |
6451027 | Cooper et al. | Sep 2002 | B1 |
6477400 | Barrick | Nov 2002 | B1 |
6484049 | Seeley et al. | Nov 2002 | B1 |
6487267 | Wolter | Nov 2002 | B1 |
6490467 | Bucholz et al. | Dec 2002 | B1 |
6490475 | Seeley et al. | Dec 2002 | B1 |
6499488 | Hunter et al. | Dec 2002 | B1 |
6501981 | Schweikard et al. | Dec 2002 | B1 |
6507751 | Blume et al. | Jan 2003 | B2 |
6535756 | Simon et al. | Mar 2003 | B1 |
6560354 | Maurer, Jr. et al. | May 2003 | B1 |
6565554 | Niemeyer | May 2003 | B1 |
6587750 | Gerbi et al. | Jul 2003 | B2 |
6614453 | Suri et al. | Sep 2003 | B1 |
6614871 | Kobiki et al. | Sep 2003 | B1 |
6619840 | Rasche et al. | Sep 2003 | B2 |
6636757 | Jascob et al. | Oct 2003 | B1 |
6645196 | Nixon et al. | Nov 2003 | B1 |
6666579 | Jensen | Dec 2003 | B2 |
6669635 | Kessman et al. | Dec 2003 | B2 |
6701173 | Nowinski et al. | Mar 2004 | B2 |
6757068 | Foxlin | Jun 2004 | B2 |
6782287 | Grzeszczuk et al. | Aug 2004 | B2 |
6783524 | Anderson et al. | Aug 2004 | B2 |
6786896 | Madhani et al. | Sep 2004 | B1 |
6788018 | Blumenkranz | Sep 2004 | B1 |
6804581 | Wang et al. | Oct 2004 | B2 |
6823207 | Jensen et al. | Nov 2004 | B1 |
6827351 | Graziani et al. | Dec 2004 | B2 |
6837892 | Shoham | Jan 2005 | B2 |
6839612 | Sanchez et al. | Jan 2005 | B2 |
6856826 | Seeley et al. | Feb 2005 | B2 |
6856827 | Seeley et al. | Feb 2005 | B2 |
6879880 | Nowlin et al. | Apr 2005 | B2 |
6892090 | Verard et al. | May 2005 | B2 |
6920347 | Simon et al. | Jul 2005 | B2 |
6922632 | Foxlin | Jul 2005 | B2 |
6968224 | Kessman et al. | Nov 2005 | B2 |
6978166 | Foley et al. | Dec 2005 | B2 |
6988009 | Grimm et al. | Jan 2006 | B2 |
6991627 | Madhani et al. | Jan 2006 | B2 |
6996487 | Jutras et al. | Feb 2006 | B2 |
6999852 | Green | Feb 2006 | B2 |
7007699 | Martinelli et al. | Mar 2006 | B2 |
7016457 | Senzig et al. | Mar 2006 | B1 |
7043961 | Pandey et al. | May 2006 | B2 |
7062006 | Pelc et al. | Jun 2006 | B1 |
7063705 | Young et al. | Jun 2006 | B2 |
7072707 | Galloway, Jr. et al. | Jul 2006 | B2 |
7083615 | Peterson et al. | Aug 2006 | B2 |
7097640 | Wang et al. | Aug 2006 | B2 |
7099428 | Clinthorne et al. | Aug 2006 | B2 |
7108421 | Gregerson et al. | Sep 2006 | B2 |
7130676 | Barrick | Oct 2006 | B2 |
7139418 | Abovitz et al. | Nov 2006 | B2 |
7139601 | Bucholz et al. | Nov 2006 | B2 |
7155316 | Sutherland et al. | Dec 2006 | B2 |
7164968 | Treat et al. | Jan 2007 | B2 |
7167738 | Schweikard et al. | Jan 2007 | B2 |
7169141 | Brock et al. | Jan 2007 | B2 |
7172627 | Fiere et al. | Feb 2007 | B2 |
7194120 | Wicker et al. | Mar 2007 | B2 |
7197107 | Arai et al. | Mar 2007 | B2 |
7207995 | Vandewalle | Apr 2007 | B1 |
7231014 | Levy | Jun 2007 | B2 |
7231063 | Naimark et al. | Jun 2007 | B2 |
7239940 | Wang et al. | Jul 2007 | B2 |
7248914 | Hastings et al. | Jul 2007 | B2 |
7301648 | Foxlin | Nov 2007 | B2 |
7302288 | Schellenberg | Nov 2007 | B1 |
7313430 | Urquhart et al. | Dec 2007 | B2 |
7318805 | Schweikard et al. | Jan 2008 | B2 |
7318827 | Leitner et al. | Jan 2008 | B2 |
7319897 | Leitner et al. | Jan 2008 | B2 |
7324623 | Heuscher et al. | Jan 2008 | B2 |
7327865 | Fu et al. | Feb 2008 | B2 |
7331967 | Lee et al. | Feb 2008 | B2 |
7333642 | Green | Feb 2008 | B2 |
7339341 | Oleynikov et al. | Mar 2008 | B2 |
7366562 | Dukesherer et al. | Apr 2008 | B2 |
7379790 | Toth et al. | May 2008 | B2 |
7386365 | Nixon | Jun 2008 | B2 |
7422592 | Morley et al. | Sep 2008 | B2 |
7435216 | Kwon et al. | Oct 2008 | B2 |
7440793 | Chauhan et al. | Oct 2008 | B2 |
7460637 | Clinthorne et al. | Dec 2008 | B2 |
7466303 | Yi et al. | Dec 2008 | B2 |
7493153 | Ahmed et al. | Feb 2009 | B2 |
7505617 | Fu et al. | Mar 2009 | B2 |
7533892 | Schena et al. | May 2009 | B2 |
7542791 | Mire et al. | Jun 2009 | B2 |
7555331 | Viswanathan | Jun 2009 | B2 |
7567834 | Clayton et al. | Jul 2009 | B2 |
7594912 | Cooper et al. | Sep 2009 | B2 |
7606613 | Simon et al. | Oct 2009 | B2 |
7607440 | Coste-Maniere et al. | Oct 2009 | B2 |
7623902 | Pacheco | Nov 2009 | B2 |
7630752 | Viswanathan | Dec 2009 | B2 |
7630753 | Simon et al. | Dec 2009 | B2 |
7643862 | Schoenefeld | Jan 2010 | B2 |
7660623 | Hunter et al. | Feb 2010 | B2 |
7661881 | Gregerson et al. | Feb 2010 | B2 |
7683331 | Chang | Mar 2010 | B2 |
7683332 | Chang | Mar 2010 | B2 |
7689320 | Prisco et al. | Mar 2010 | B2 |
7691098 | Wallace et al. | Apr 2010 | B2 |
7702379 | Avinash et al. | Apr 2010 | B2 |
7702477 | Tuemmler et al. | Apr 2010 | B2 |
7711083 | Heigl et al. | May 2010 | B2 |
7711406 | Kuhn et al. | May 2010 | B2 |
7720523 | Omernick et al. | May 2010 | B2 |
7725253 | Foxlin | May 2010 | B2 |
7726171 | Langlotz et al. | Jun 2010 | B2 |
7742801 | Neubauer et al. | Jun 2010 | B2 |
7751865 | Jascob et al. | Jul 2010 | B2 |
7760849 | Zhang | Jul 2010 | B2 |
7762825 | Burbank et al. | Jul 2010 | B2 |
7763015 | Cooper et al. | Jul 2010 | B2 |
7787699 | Mahesh et al. | Aug 2010 | B2 |
7796728 | Bergfjord | Sep 2010 | B2 |
7813838 | Sommer | Oct 2010 | B2 |
7818044 | Dukesherer et al. | Oct 2010 | B2 |
7819859 | Prisco et al. | Oct 2010 | B2 |
7824401 | Manzo et al. | Nov 2010 | B2 |
7831294 | Viswanathan | Nov 2010 | B2 |
7834484 | Sartor | Nov 2010 | B2 |
7835557 | Kendrick et al. | Nov 2010 | B2 |
7835778 | Foley et al. | Nov 2010 | B2 |
7835784 | Mire et al. | Nov 2010 | B2 |
7840253 | Tremblay et al. | Nov 2010 | B2 |
7840256 | Lakin et al. | Nov 2010 | B2 |
7843158 | Prisco | Nov 2010 | B2 |
7844320 | Shahidi | Nov 2010 | B2 |
7853305 | Simon et al. | Dec 2010 | B2 |
7853313 | Thompson | Dec 2010 | B2 |
7865269 | Prisco et al. | Jan 2011 | B2 |
D631966 | Perloff et al. | Feb 2011 | S |
7879045 | Gielen et al. | Feb 2011 | B2 |
7881767 | Strommer et al. | Feb 2011 | B2 |
7881770 | Melkent et al. | Feb 2011 | B2 |
7886743 | Cooper et al. | Feb 2011 | B2 |
RE42194 | Foley et al. | Mar 2011 | E |
RE42226 | Foley et al. | Mar 2011 | E |
7900524 | Calloway et al. | Mar 2011 | B2 |
7907166 | Lamprecht et al. | Mar 2011 | B2 |
7909122 | Schena et al. | Mar 2011 | B2 |
7925653 | Saptharishi | Apr 2011 | B2 |
7930065 | Larkin et al. | Apr 2011 | B2 |
7935130 | Willliams | May 2011 | B2 |
7940999 | Liao et al. | May 2011 | B2 |
7945012 | Ye et al. | May 2011 | B2 |
7945021 | Shapiro et al. | May 2011 | B2 |
7953470 | Vetter et al. | May 2011 | B2 |
7954397 | Choi et al. | Jun 2011 | B2 |
7971341 | Dukesherer et al. | Jul 2011 | B2 |
7974674 | Hauck et al. | Jul 2011 | B2 |
7974677 | Mire et al. | Jul 2011 | B2 |
7974681 | Wallace et al. | Jul 2011 | B2 |
7979157 | Anvari | Jul 2011 | B2 |
7983733 | Viswanathan | Jul 2011 | B2 |
7988215 | Seibold | Aug 2011 | B2 |
7996110 | Lipow et al. | Aug 2011 | B2 |
8004121 | Sartor | Aug 2011 | B2 |
8004229 | Nowlin et al. | Aug 2011 | B2 |
8010177 | Csavoy et al. | Aug 2011 | B2 |
8019045 | Kato | Sep 2011 | B2 |
8021310 | Sanborn et al. | Sep 2011 | B2 |
8035685 | Jensen | Oct 2011 | B2 |
8046054 | Kim et al. | Oct 2011 | B2 |
8046057 | Clarke | Oct 2011 | B2 |
8052688 | Wolf, II | Nov 2011 | B2 |
8054184 | Cline et al. | Nov 2011 | B2 |
8054752 | Druke et al. | Nov 2011 | B2 |
8057397 | Li et al. | Nov 2011 | B2 |
8057407 | Martinelli et al. | Nov 2011 | B2 |
8062288 | Cooper et al. | Nov 2011 | B2 |
8062375 | Glerum et al. | Nov 2011 | B2 |
8066524 | Burbank et al. | Nov 2011 | B2 |
8073335 | Labonville et al. | Dec 2011 | B2 |
8079950 | Stern et al. | Dec 2011 | B2 |
8086299 | Adler et al. | Dec 2011 | B2 |
8092370 | Roberts et al. | Jan 2012 | B2 |
8098914 | Liao et al. | Jan 2012 | B2 |
8100950 | St. Clair et al. | Jan 2012 | B2 |
8105320 | Manzo | Jan 2012 | B2 |
8108025 | Csavoy et al. | Jan 2012 | B2 |
8109877 | Moctezuma de la Barrera et al. | Feb 2012 | B2 |
8112292 | Simon | Feb 2012 | B2 |
8116430 | Shapiro et al. | Feb 2012 | B1 |
8120301 | Goldberg et al. | Feb 2012 | B2 |
8121249 | Wang et al. | Feb 2012 | B2 |
8123675 | Funda et al. | Feb 2012 | B2 |
8133229 | Bonutti | Mar 2012 | B1 |
8142420 | Schena | Mar 2012 | B2 |
8147494 | Leitner et al. | Apr 2012 | B2 |
8150494 | Simon et al. | Apr 2012 | B2 |
8150497 | Gielen et al. | Apr 2012 | B2 |
8150498 | Gielen et al. | Apr 2012 | B2 |
8165658 | Waynik et al. | Apr 2012 | B2 |
8170313 | Kendrick et al. | May 2012 | B2 |
8179073 | Farritor et al. | May 2012 | B2 |
8182476 | Julian et al. | May 2012 | B2 |
8184880 | Zhao et al. | May 2012 | B2 |
8202278 | Orban, III et al. | Jun 2012 | B2 |
8208708 | Homan et al. | Jun 2012 | B2 |
8208988 | Jensen | Jun 2012 | B2 |
8219177 | Smith et al. | Jul 2012 | B2 |
8219178 | Smith et al. | Jul 2012 | B2 |
8220468 | Cooper et al. | Jul 2012 | B2 |
8224024 | Foxlin et al. | Jul 2012 | B2 |
8224484 | Swarup et al. | Jul 2012 | B2 |
8225798 | Baldwin et al. | Jul 2012 | B2 |
8228368 | Zhao et al. | Jul 2012 | B2 |
8231610 | Jo et al. | Jul 2012 | B2 |
8263933 | Hartmann et al. | Jul 2012 | B2 |
8239001 | Verard et al. | Aug 2012 | B2 |
8241271 | Millman et al. | Aug 2012 | B2 |
8248413 | Gattani et al. | Aug 2012 | B2 |
8256319 | Cooper et al. | Sep 2012 | B2 |
8271069 | Jascob et al. | Sep 2012 | B2 |
8271130 | Hourtash | Sep 2012 | B2 |
8281670 | Larkin et al. | Oct 2012 | B2 |
8282653 | Nelson et al. | Oct 2012 | B2 |
8301226 | Csavoy et al. | Oct 2012 | B2 |
8311611 | Csavoy et al. | Nov 2012 | B2 |
8313430 | Pimenta | Nov 2012 | B1 |
8320991 | Jascob et al. | Nov 2012 | B2 |
8332012 | Kienzle, III | Dec 2012 | B2 |
8333755 | Cooper et al. | Dec 2012 | B2 |
8335552 | Stiles | Dec 2012 | B2 |
8335557 | Maschke | Dec 2012 | B2 |
8348931 | Cooper et al. | Jan 2013 | B2 |
8353963 | Glerum | Jan 2013 | B2 |
8358818 | Miga et al. | Jan 2013 | B2 |
8359730 | Burg et al. | Jan 2013 | B2 |
8374673 | Adcox et al. | Feb 2013 | B2 |
8374723 | Zhao et al. | Feb 2013 | B2 |
8379791 | Forthmann et al. | Feb 2013 | B2 |
8386019 | Camus et al. | Feb 2013 | B2 |
8392022 | Ortmaier et al. | Mar 2013 | B2 |
8394099 | Patwardhan | Mar 2013 | B2 |
8395342 | Prisco | Mar 2013 | B2 |
8398634 | Manzo et al. | Mar 2013 | B2 |
8400094 | Schena | Mar 2013 | B2 |
8414957 | Enzerink et al. | Apr 2013 | B2 |
8418073 | Mohr et al. | Apr 2013 | B2 |
8450694 | Baviera et al. | May 2013 | B2 |
8452447 | Nixon | May 2013 | B2 |
RE44305 | Foley et al. | Jun 2013 | E |
8462911 | Vesel et al. | Jun 2013 | B2 |
8465476 | Rogers et al. | Jun 2013 | B2 |
8465771 | Wan et al. | Jun 2013 | B2 |
8467851 | Mire et al. | Jun 2013 | B2 |
8467852 | Csavoy et al. | Jun 2013 | B2 |
8469947 | Devengenzo et al. | Jun 2013 | B2 |
RE44392 | Hynes | Jul 2013 | E |
8483434 | Buehner et al. | Jul 2013 | B2 |
8483800 | Jensen et al. | Jul 2013 | B2 |
8486532 | Enzerink et al. | Jul 2013 | B2 |
8489235 | Moll et al. | Jul 2013 | B2 |
8500722 | Cooper | Aug 2013 | B2 |
8500728 | Newton et al. | Aug 2013 | B2 |
8504201 | Moll et al. | Aug 2013 | B2 |
8506555 | Ruiz Morales | Aug 2013 | B2 |
8506556 | Schena | Aug 2013 | B2 |
8508173 | Goldberg et al. | Aug 2013 | B2 |
8512318 | Tovey et al. | Aug 2013 | B2 |
8515576 | Lipow et al. | Aug 2013 | B2 |
8518120 | Glerum et al. | Aug 2013 | B2 |
8521331 | Itkowitz | Aug 2013 | B2 |
8526688 | Groszmann et al. | Sep 2013 | B2 |
8526700 | Isaacs | Sep 2013 | B2 |
8527094 | Kumar et al. | Sep 2013 | B2 |
8528440 | Morley et al. | Sep 2013 | B2 |
8532741 | Heruth et al. | Sep 2013 | B2 |
8541970 | Nowlin et al. | Sep 2013 | B2 |
8548563 | Simon et al. | Oct 2013 | B2 |
8549732 | Burg et al. | Oct 2013 | B2 |
8551114 | Ramos de la Pena | Oct 2013 | B2 |
8551116 | Julian et al. | Oct 2013 | B2 |
8556807 | Scott et al. | Oct 2013 | B2 |
8556979 | Glerum et al. | Oct 2013 | B2 |
8560118 | Green et al. | Oct 2013 | B2 |
8561473 | Blumenkranz | Oct 2013 | B2 |
8562594 | Cooper et al. | Oct 2013 | B2 |
8571638 | Shoham | Oct 2013 | B2 |
8571710 | Coste-Maniere et al. | Oct 2013 | B2 |
8573465 | Shelton, IV | Nov 2013 | B2 |
8574303 | Sharkey | Nov 2013 | B2 |
8585420 | Burbank et al. | Nov 2013 | B2 |
8594841 | Zhao et al. | Nov 2013 | B2 |
8597198 | Sanborn et al. | Dec 2013 | B2 |
8600478 | Verard et al. | Dec 2013 | B2 |
8603077 | Cooper et al. | Dec 2013 | B2 |
8611985 | Lavallee et al. | Dec 2013 | B2 |
8613230 | Blumenkranz et al. | Dec 2013 | B2 |
8621939 | Blumenkranz et al. | Jan 2014 | B2 |
8624537 | Nowlin et al. | Jan 2014 | B2 |
8630389 | Kato | Jan 2014 | B2 |
8634897 | Simon et al. | Jan 2014 | B2 |
8634957 | Toth et al. | Jan 2014 | B2 |
8638056 | Goldberg et al. | Jan 2014 | B2 |
8638057 | Goldberg et al. | Jan 2014 | B2 |
8639000 | Zhao et al. | Jan 2014 | B2 |
8641726 | Bonutti | Feb 2014 | B2 |
8644907 | Hartmann et al. | Feb 2014 | B2 |
8657809 | Schoepp | Feb 2014 | B2 |
8660635 | Simon et al. | Feb 2014 | B2 |
8666544 | Moll et al. | Mar 2014 | B2 |
8675939 | Moctezuma de la Barrera | Mar 2014 | B2 |
8678647 | Gregerson et al. | Mar 2014 | B2 |
8679125 | Smith et al. | Mar 2014 | B2 |
8679183 | Glerum et al. | Mar 2014 | B2 |
8682413 | Lloyd | Mar 2014 | B2 |
8684253 | Giordano et al. | Apr 2014 | B2 |
8685098 | Glerum et al. | Apr 2014 | B2 |
8693730 | Umasuthan et al. | Apr 2014 | B2 |
8694075 | Groszmann et al. | Apr 2014 | B2 |
8696458 | Foxlin et al. | Apr 2014 | B2 |
8700123 | Okamura et al. | Apr 2014 | B2 |
8706086 | Glerum | Apr 2014 | B2 |
8706185 | Foley et al. | Apr 2014 | B2 |
8706301 | Zhao et al. | Apr 2014 | B2 |
8717430 | Simon et al. | May 2014 | B2 |
8727618 | Maschke et al. | May 2014 | B2 |
8734432 | Tuma et al. | May 2014 | B2 |
8738115 | Amberg et al. | May 2014 | B2 |
8738181 | Greer et al. | May 2014 | B2 |
8740882 | Jun et al. | Jun 2014 | B2 |
8746252 | McGrogan et al. | Jun 2014 | B2 |
8749189 | Nowlin et al. | Jun 2014 | B2 |
8749190 | Nowlin et al. | Jun 2014 | B2 |
8761930 | Nixon | Jun 2014 | B2 |
8764448 | Yang et al. | Jul 2014 | B2 |
8771170 | Mesallum et al. | Jul 2014 | B2 |
8781186 | Clements et al. | Jul 2014 | B2 |
8781630 | Banks et al. | Jul 2014 | B2 |
8784385 | Boyden et al. | Jul 2014 | B2 |
8786241 | Nowlin et al. | Jul 2014 | B2 |
8787520 | Baba | Jul 2014 | B2 |
8792704 | Isaacs | Jul 2014 | B2 |
8798231 | Notohara et al. | Aug 2014 | B2 |
8800838 | Shelton, IV | Aug 2014 | B2 |
8808164 | Hoffman et al. | Aug 2014 | B2 |
8812077 | Dempsey | Aug 2014 | B2 |
8814793 | Brabrand | Aug 2014 | B2 |
8816628 | Nowlin et al. | Aug 2014 | B2 |
8818105 | Myronenko et al. | Aug 2014 | B2 |
8820605 | Shelton, IV | Sep 2014 | B2 |
8821511 | Von Jako et al. | Sep 2014 | B2 |
8823308 | Nowlin et al. | Sep 2014 | B2 |
8827996 | Scott et al. | Sep 2014 | B2 |
8828024 | Farritor et al. | Sep 2014 | B2 |
8830224 | Zhao et al. | Sep 2014 | B2 |
8834489 | Cooper et al. | Sep 2014 | B2 |
8834490 | Bonutti | Sep 2014 | B2 |
8838270 | Druke et al. | Sep 2014 | B2 |
8844789 | Shelton, IV et al. | Sep 2014 | B2 |
8855822 | Bartol et al. | Oct 2014 | B2 |
8858598 | Seifert et al. | Oct 2014 | B2 |
8860753 | Bhandarkar et al. | Oct 2014 | B2 |
8864751 | Prisco et al. | Oct 2014 | B2 |
8864798 | Weiman et al. | Oct 2014 | B2 |
8864833 | Glerum et al. | Oct 2014 | B2 |
8867703 | Shapiro et al. | Oct 2014 | B2 |
8870880 | Himmelberger et al. | Oct 2014 | B2 |
8876866 | Zappacosta et al. | Nov 2014 | B2 |
8880223 | Raj et al. | Nov 2014 | B2 |
8882803 | Iott et al. | Nov 2014 | B2 |
8883210 | Truncale et al. | Nov 2014 | B1 |
8888821 | Rezach et al. | Nov 2014 | B2 |
8888853 | Glerum et al. | Nov 2014 | B2 |
8888854 | Glerum et al. | Nov 2014 | B2 |
8894652 | Seifert et al. | Nov 2014 | B2 |
8894688 | Suh | Nov 2014 | B2 |
8894691 | Iott et al. | Nov 2014 | B2 |
8906069 | Hansell et al. | Dec 2014 | B2 |
8964934 | Ein-Gal | Feb 2015 | B2 |
8992580 | Bar et al. | Mar 2015 | B2 |
8996169 | Lightcap et al. | Mar 2015 | B2 |
9001963 | Sowards-Emmerd et al. | Apr 2015 | B2 |
9002076 | Khadem et al. | Apr 2015 | B2 |
9044190 | Rubner et al. | Jun 2015 | B2 |
9107683 | Hourtash et al. | Aug 2015 | B2 |
9125556 | Zehavi et al. | Sep 2015 | B2 |
9131986 | Greer et al. | Sep 2015 | B2 |
9215968 | Schostek et al. | Dec 2015 | B2 |
9280823 | Popovic | Mar 2016 | B2 |
9308050 | Kostrzewski et al. | Apr 2016 | B2 |
9351709 | Hague | May 2016 | B2 |
9380984 | Li et al. | Jul 2016 | B2 |
9393039 | Lechner et al. | Jul 2016 | B2 |
9398886 | Gregerson et al. | Jul 2016 | B2 |
9398890 | Dong et al. | Jul 2016 | B2 |
9414859 | Ballard et al. | Aug 2016 | B2 |
9420975 | Gutfleisch et al. | Aug 2016 | B2 |
9463073 | Gill et al. | Oct 2016 | B2 |
9492235 | Hourtash et al. | Nov 2016 | B2 |
9554117 | Lee | Jan 2017 | B2 |
9592096 | Maillet et al. | Mar 2017 | B2 |
9615886 | Popovic | Apr 2017 | B2 |
9750465 | Engel et al. | Sep 2017 | B2 |
9757203 | Hourtash et al. | Sep 2017 | B2 |
9782229 | Crawford | Oct 2017 | B2 |
9795354 | Menegaz et al. | Oct 2017 | B2 |
9814535 | Bar et al. | Nov 2017 | B2 |
9820783 | Donner et al. | Nov 2017 | B2 |
9833265 | Donner et al. | Nov 2017 | B2 |
9848922 | Meh et al. | Dec 2017 | B2 |
9925011 | Gombert et al. | Mar 2018 | B2 |
9931025 | Graetzel et al. | Apr 2018 | B1 |
10034717 | Miller et al. | Jul 2018 | B2 |
10182704 | Popovic | Jan 2019 | B2 |
10357184 | Crawford | Jul 2019 | B2 |
10575906 | Wu | Mar 2020 | B2 |
10893912 | Crawford | Jan 2021 | B2 |
11020202 | Wada | Jun 2021 | B2 |
11109843 | Li | Sep 2021 | B2 |
20010036302 | Miller | Nov 2001 | A1 |
20020035321 | Bucholz et al. | Mar 2002 | A1 |
20030125622 | Schweikard et al. | Jul 2003 | A1 |
20030161442 | Zeiss | Aug 2003 | A1 |
20040019263 | Jutras et al. | Jan 2004 | A1 |
20040024311 | Quaid | Feb 2004 | A1 |
20040034302 | Abovitz et al. | Feb 2004 | A1 |
20040068172 | Nowinski et al. | Apr 2004 | A1 |
20040076259 | Jensen et al. | Apr 2004 | A1 |
20040157188 | Luth et al. | Aug 2004 | A1 |
20050085714 | Foley et al. | Apr 2005 | A1 |
20050096502 | Khalili | May 2005 | A1 |
20050107679 | Geiger et al. | May 2005 | A1 |
20050119639 | McCombs et al. | Jun 2005 | A1 |
20050143651 | Verard et al. | Jun 2005 | A1 |
20050149045 | Elliott | Jul 2005 | A1 |
20050171558 | Abovitz et al. | Aug 2005 | A1 |
20050215888 | Grimm et al. | Sep 2005 | A1 |
20060036264 | Selover et al. | Feb 2006 | A1 |
20060100610 | Wallace et al. | May 2006 | A1 |
20060142657 | Quaid et al. | Jun 2006 | A1 |
20060173329 | Marquart et al. | Aug 2006 | A1 |
20060178559 | Kumar et al. | Aug 2006 | A1 |
20060184396 | Dennis et al. | Aug 2006 | A1 |
20060241416 | Marquart et al. | Oct 2006 | A1 |
20060264963 | Reed et al. | Nov 2006 | A1 |
20060291612 | Nishide et al. | Dec 2006 | A1 |
20070001879 | Kaftan et al. | Jan 2007 | A1 |
20070015987 | Benlloch Baviera et al. | Jan 2007 | A1 |
20070016009 | Lakin et al. | Jan 2007 | A1 |
20070021738 | Hasser et al. | Jan 2007 | A1 |
20070038059 | Sheffer et al. | Feb 2007 | A1 |
20070073133 | Schoenefeld | Mar 2007 | A1 |
20070122020 | Claus et al. | May 2007 | A1 |
20070156121 | Millman et al. | Jul 2007 | A1 |
20070156157 | Nahum et al. | Jul 2007 | A1 |
20070167712 | Keglovich et al. | Jul 2007 | A1 |
20070233238 | Huynh et al. | Oct 2007 | A1 |
20070238985 | Smith et al. | Oct 2007 | A1 |
20080004523 | Jensen | Jan 2008 | A1 |
20080010706 | Moses et al. | Jan 2008 | A1 |
20080013809 | Zhu et al. | Jan 2008 | A1 |
20080033283 | Dellaca et al. | Feb 2008 | A1 |
20080046122 | Manzo et al. | Feb 2008 | A1 |
20080082109 | Moll et al. | Apr 2008 | A1 |
20080108912 | Node-Langlois | May 2008 | A1 |
20080108991 | Von Jako | May 2008 | A1 |
20080109012 | Falco et al. | May 2008 | A1 |
20080119725 | Lloyd | May 2008 | A1 |
20080144906 | Allred et al. | Jun 2008 | A1 |
20080154389 | Smith et al. | Jun 2008 | A1 |
20080161680 | Von Jako et al. | Jul 2008 | A1 |
20080161682 | Kendrick et al. | Jul 2008 | A1 |
20080177203 | von Jako | Jul 2008 | A1 |
20080188934 | Moser et al. | Aug 2008 | A1 |
20080200794 | Teichman et al. | Aug 2008 | A1 |
20080214922 | Hartmann et al. | Sep 2008 | A1 |
20080228068 | Viswanathan et al. | Sep 2008 | A1 |
20080228195 | von Jako et al. | Sep 2008 | A1 |
20080228196 | Wang et al. | Sep 2008 | A1 |
20080235052 | Node-Langlois et al. | Sep 2008 | A1 |
20080269596 | Revie et al. | Oct 2008 | A1 |
20080287771 | Anderson | Nov 2008 | A1 |
20080287781 | Revie et al. | Nov 2008 | A1 |
20080300477 | Lloyd et al. | Dec 2008 | A1 |
20080300478 | Zuhars et al. | Dec 2008 | A1 |
20080302950 | Park et al. | Dec 2008 | A1 |
20080306490 | Lakin et al. | Dec 2008 | A1 |
20080319311 | Hamadeh | Dec 2008 | A1 |
20090012509 | Csavoy et al. | Jan 2009 | A1 |
20090030428 | Omori et al. | Jan 2009 | A1 |
20090080737 | Battle et al. | Mar 2009 | A1 |
20090099445 | Burger | Apr 2009 | A1 |
20090185655 | Koken et al. | Jul 2009 | A1 |
20090198121 | Hoheisel | Aug 2009 | A1 |
20090216113 | Meier et al. | Aug 2009 | A1 |
20090228019 | Gross et al. | Sep 2009 | A1 |
20090234217 | Mire et al. | Sep 2009 | A1 |
20090240141 | Neubauer et al. | Sep 2009 | A1 |
20090254326 | Isaacs | Oct 2009 | A1 |
20090259123 | Navab et al. | Oct 2009 | A1 |
20090259230 | Khadem et al. | Oct 2009 | A1 |
20090264899 | Appenrodt et al. | Oct 2009 | A1 |
20090281417 | Hartmann et al. | Nov 2009 | A1 |
20090306480 | Protopsaltis | Dec 2009 | A1 |
20090306499 | Van Vorhis et al. | Dec 2009 | A1 |
20100022874 | Wang et al. | Jan 2010 | A1 |
20100039506 | Sarvestani et al. | Feb 2010 | A1 |
20100046718 | Weiser et al. | Feb 2010 | A1 |
20100076305 | Maier-Hein et al. | Mar 2010 | A1 |
20100114288 | Haller et al. | May 2010 | A1 |
20100125286 | Wang et al. | May 2010 | A1 |
20100130986 | Mailloux et al. | May 2010 | A1 |
20100174410 | Greer et al. | Jul 2010 | A1 |
20100228117 | Hartmann | Sep 2010 | A1 |
20100228265 | Prisco | Sep 2010 | A1 |
20100228340 | Erbel et al. | Sep 2010 | A1 |
20100249571 | Jensen et al. | Sep 2010 | A1 |
20100274120 | Heuscher | Oct 2010 | A1 |
20100280363 | Skarda et al. | Nov 2010 | A1 |
20100331858 | Simaan et al. | Dec 2010 | A1 |
20110019884 | Blau | Jan 2011 | A1 |
20110020084 | Brett et al. | Jan 2011 | A1 |
20110022229 | Jang et al. | Jan 2011 | A1 |
20110040305 | Gomez et al. | Feb 2011 | A1 |
20110071347 | Rogers et al. | Mar 2011 | A1 |
20110077504 | Fischer et al. | Mar 2011 | A1 |
20110082468 | Hagag et al. | Apr 2011 | A1 |
20110098553 | Robbins et al. | Apr 2011 | A1 |
20110137152 | Li | Jun 2011 | A1 |
20110184245 | Xia et al. | Jul 2011 | A1 |
20110190588 | McKay | Aug 2011 | A1 |
20110213379 | Blau et al. | Sep 2011 | A1 |
20110213384 | Jeong | Sep 2011 | A1 |
20110224684 | Larkin et al. | Sep 2011 | A1 |
20110224685 | Larkin et al. | Sep 2011 | A1 |
20110224686 | Larkin et al. | Sep 2011 | A1 |
20110224687 | Larkin et al. | Sep 2011 | A1 |
20110224688 | Larkin et al. | Sep 2011 | A1 |
20110224689 | Larkin et al. | Sep 2011 | A1 |
20110224825 | Larkin et al. | Sep 2011 | A1 |
20110230967 | O'Halloran et al. | Sep 2011 | A1 |
20110238080 | Ranjit et al. | Sep 2011 | A1 |
20110257653 | Hughes et al. | Oct 2011 | A1 |
20110276058 | Choi et al. | Nov 2011 | A1 |
20110282189 | Graumann | Nov 2011 | A1 |
20110286573 | Schretter et al. | Nov 2011 | A1 |
20110295062 | Gratacos Solsona et al. | Dec 2011 | A1 |
20110295370 | Suh et al. | Dec 2011 | A1 |
20110306986 | Lee et al. | Dec 2011 | A1 |
20120035507 | George et al. | Feb 2012 | A1 |
20120046668 | Gantes | Feb 2012 | A1 |
20120051498 | Koishi | Mar 2012 | A1 |
20120053597 | Anvari et al. | Mar 2012 | A1 |
20120059248 | Holsing et al. | Mar 2012 | A1 |
20120071753 | Hunter et al. | Mar 2012 | A1 |
20120108954 | Schulhauser et al. | May 2012 | A1 |
20120136372 | Amat Girbau et al. | May 2012 | A1 |
20120143084 | Shoham | Jun 2012 | A1 |
20120184839 | Woerlein | Jul 2012 | A1 |
20120197182 | Millman et al. | Aug 2012 | A1 |
20120226145 | Chang et al. | Sep 2012 | A1 |
20120235909 | Birkenbach et al. | Sep 2012 | A1 |
20120245596 | Meenink | Sep 2012 | A1 |
20120253332 | Moll | Oct 2012 | A1 |
20120253360 | White et al. | Oct 2012 | A1 |
20120256092 | Zingerman | Oct 2012 | A1 |
20120289820 | Rohling | Nov 2012 | A1 |
20120294498 | Popovic | Nov 2012 | A1 |
20120296203 | Hartmann et al. | Nov 2012 | A1 |
20130006267 | Odermatt et al. | Jan 2013 | A1 |
20130016889 | Myronenko et al. | Jan 2013 | A1 |
20130030571 | Ruiz Morales et al. | Jan 2013 | A1 |
20130035583 | Park et al. | Feb 2013 | A1 |
20130051647 | Miao et al. | Feb 2013 | A1 |
20130053679 | Owen | Feb 2013 | A1 |
20130060146 | Yang et al. | Mar 2013 | A1 |
20130060337 | Petersheim et al. | Mar 2013 | A1 |
20130064427 | Picard et al. | Mar 2013 | A1 |
20130094742 | Feilkas | Apr 2013 | A1 |
20130096574 | Kang et al. | Apr 2013 | A1 |
20130113791 | Isaacs et al. | May 2013 | A1 |
20130116706 | Lee et al. | May 2013 | A1 |
20130131695 | Scarfogliero et al. | May 2013 | A1 |
20130144307 | Jeong et al. | Jun 2013 | A1 |
20130158542 | Manzo et al. | Jun 2013 | A1 |
20130165937 | Patwardhan | Jun 2013 | A1 |
20130165948 | Popovic | Jun 2013 | A1 |
20130178867 | Farritor et al. | Jul 2013 | A1 |
20130178868 | Roh | Jul 2013 | A1 |
20130178870 | Schena | Jul 2013 | A1 |
20130184873 | Namiki | Jul 2013 | A1 |
20130204271 | Brisson et al. | Aug 2013 | A1 |
20130211419 | Jensen | Aug 2013 | A1 |
20130211420 | Jensen | Aug 2013 | A1 |
20130218142 | Tuma et al. | Aug 2013 | A1 |
20130223702 | Holsing et al. | Aug 2013 | A1 |
20130225942 | Holsing et al. | Aug 2013 | A1 |
20130225943 | Holsing et al. | Aug 2013 | A1 |
20130231556 | Holsing et al. | Sep 2013 | A1 |
20130237995 | Lee et al. | Sep 2013 | A1 |
20130245375 | DiMaio et al. | Sep 2013 | A1 |
20130261640 | Kim et al. | Oct 2013 | A1 |
20130268007 | Rezach et al. | Oct 2013 | A1 |
20130272488 | Bailey et al. | Oct 2013 | A1 |
20130272489 | Dickman et al. | Oct 2013 | A1 |
20130274761 | Devengenzo et al. | Oct 2013 | A1 |
20130279784 | Gill et al. | Oct 2013 | A1 |
20130281821 | Liu et al. | Oct 2013 | A1 |
20130296884 | Taylor et al. | Nov 2013 | A1 |
20130303887 | Holsing et al. | Nov 2013 | A1 |
20130307955 | Deitz et al. | Nov 2013 | A1 |
20130317521 | Choi et al. | Nov 2013 | A1 |
20130325033 | Schena et al. | Dec 2013 | A1 |
20130325035 | Hauck et al. | Dec 2013 | A1 |
20130331686 | Freysinger et al. | Dec 2013 | A1 |
20130331858 | Devengenzo et al. | Dec 2013 | A1 |
20130331861 | Koon | Dec 2013 | A1 |
20130342578 | Isaacs | Dec 2013 | A1 |
20130345717 | Markvicka et al. | Dec 2013 | A1 |
20130345718 | Crawford et al. | Dec 2013 | A1 |
20130345757 | Stad | Dec 2013 | A1 |
20140001235 | Shelton, IV | Jan 2014 | A1 |
20140012131 | Heruth et al. | Jan 2014 | A1 |
20140031664 | Kang et al. | Jan 2014 | A1 |
20140046128 | Lee et al. | Feb 2014 | A1 |
20140046132 | Hoeg et al. | Feb 2014 | A1 |
20140046340 | Wilson et al. | Feb 2014 | A1 |
20140049629 | Siewerdsen et al. | Feb 2014 | A1 |
20140052150 | Taylor et al. | Feb 2014 | A1 |
20140058406 | Tsekos | Feb 2014 | A1 |
20140073914 | Lavallee et al. | Mar 2014 | A1 |
20140080086 | Chen | Mar 2014 | A1 |
20140081128 | Verard et al. | Mar 2014 | A1 |
20140088410 | Wu | Mar 2014 | A1 |
20140088612 | Bartol et al. | Mar 2014 | A1 |
20140094694 | Moctezuma de la Barrera | Apr 2014 | A1 |
20140094851 | Gordon | Apr 2014 | A1 |
20140096369 | Matsumoto et al. | Apr 2014 | A1 |
20140100587 | Farritor et al. | Apr 2014 | A1 |
20140121676 | Kostrzewski et al. | May 2014 | A1 |
20140128882 | Kwak et al. | May 2014 | A1 |
20140135744 | Stein et al. | May 2014 | A1 |
20140135796 | Simon et al. | May 2014 | A1 |
20140142591 | Alvarez et al. | May 2014 | A1 |
20140142592 | Moon et al. | May 2014 | A1 |
20140148692 | Hartmann et al. | May 2014 | A1 |
20140163581 | Devengenzo et al. | Jun 2014 | A1 |
20140171781 | Stiles | Jun 2014 | A1 |
20140171900 | Stiles | Jun 2014 | A1 |
20140171965 | Loh et al. | Jun 2014 | A1 |
20140180308 | von Grunberg | Jun 2014 | A1 |
20140180309 | Seeber et al. | Jun 2014 | A1 |
20140187915 | Yaroshenko et al. | Jul 2014 | A1 |
20140188132 | Kang | Jul 2014 | A1 |
20140194699 | Roh et al. | Jul 2014 | A1 |
20140200587 | Pompee et al. | Jul 2014 | A1 |
20140130810 | Azizian et al. | Aug 2014 | A1 |
20140221819 | Sarment | Aug 2014 | A1 |
20140221822 | Ehlers et al. | Aug 2014 | A1 |
20140222023 | Kim et al. | Aug 2014 | A1 |
20140228631 | Kwak et al. | Aug 2014 | A1 |
20140234804 | Huang et al. | Aug 2014 | A1 |
20140257328 | Kim et al. | Sep 2014 | A1 |
20140257329 | Jang et al. | Sep 2014 | A1 |
20140257330 | Choi et al. | Sep 2014 | A1 |
20140275760 | Lee et al. | Sep 2014 | A1 |
20140275955 | Crawford et al. | Sep 2014 | A1 |
20140275985 | Walker et al. | Sep 2014 | A1 |
20140276931 | Parihar et al. | Sep 2014 | A1 |
20140276940 | Seo | Sep 2014 | A1 |
20140276943 | Bowling et al. | Sep 2014 | A1 |
20140276944 | Farritor et al. | Sep 2014 | A1 |
20140288413 | Hwang et al. | Sep 2014 | A1 |
20140299648 | Shelton, IV et al. | Oct 2014 | A1 |
20140303434 | Farritor et al. | Oct 2014 | A1 |
20140303643 | Ha et al. | Oct 2014 | A1 |
20140305995 | Shelton, IV et al. | Oct 2014 | A1 |
20140309659 | Roh et al. | Oct 2014 | A1 |
20140316420 | Ballard et al. | Oct 2014 | A1 |
20140316436 | Bar et al. | Oct 2014 | A1 |
20140323803 | Hoffman et al. | Oct 2014 | A1 |
20140324070 | Min et al. | Oct 2014 | A1 |
20140330288 | Date et al. | Nov 2014 | A1 |
20140336669 | Park | Nov 2014 | A1 |
20140343416 | Panescu et al. | Nov 2014 | A1 |
20140347353 | Popovic | Nov 2014 | A1 |
20140357989 | Hendriks et al. | Dec 2014 | A1 |
20140364720 | Darrow et al. | Dec 2014 | A1 |
20140371577 | Maillet et al. | Dec 2014 | A1 |
20150032164 | Crawford et al. | Jan 2015 | A1 |
20150039034 | Frankel et al. | Feb 2015 | A1 |
20150049174 | Lee | Feb 2015 | A1 |
20150085970 | Bouhnik et al. | Mar 2015 | A1 |
20150100066 | Kostrzewski et al. | Apr 2015 | A1 |
20150146847 | Liu | May 2015 | A1 |
20150150524 | Yorkston et al. | Jun 2015 | A1 |
20150157416 | Andersson | Jun 2015 | A1 |
20150157468 | Wakayama et al. | Jun 2015 | A1 |
20150173810 | Biedermann et al. | Jun 2015 | A1 |
20150196261 | Funk | Jul 2015 | A1 |
20150196365 | Kostrzewski et al. | Jul 2015 | A1 |
20150209056 | Shoham et al. | Jul 2015 | A1 |
20150213633 | Chang et al. | Jul 2015 | A1 |
20150335480 | Alvarez et al. | Nov 2015 | A1 |
20150342647 | Frankel et al. | Dec 2015 | A1 |
20160005194 | Schretter et al. | Jan 2016 | A1 |
20160063707 | Masumoto | Mar 2016 | A1 |
20160166329 | Langan et al. | Jun 2016 | A1 |
20160220320 | Crawford et al. | Aug 2016 | A1 |
20160235480 | Scholl et al. | Aug 2016 | A1 |
20160235492 | Morard et al. | Aug 2016 | A1 |
20160235493 | Leboeuf, II et al. | Aug 2016 | A1 |
20160249990 | Glozman et al. | Sep 2016 | A1 |
20160256225 | Crawford et al. | Sep 2016 | A1 |
20160296266 | Chandanson et al. | Oct 2016 | A1 |
20160302871 | Gregerson et al. | Oct 2016 | A1 |
20160320322 | Suzuki | Nov 2016 | A1 |
20160331335 | Gregerson et al. | Nov 2016 | A1 |
20170000562 | Frank et al. | Jan 2017 | A1 |
20170007327 | Haider et al. | Jan 2017 | A1 |
20170020609 | Wentorf et al. | Jan 2017 | A1 |
20170079727 | Crawford et al. | Mar 2017 | A1 |
20170112552 | Sinnott et al. | Apr 2017 | A1 |
20170135770 | Scholl et al. | May 2017 | A1 |
20170143284 | Sehnert et al. | May 2017 | A1 |
20170143426 | Isaacs et al. | May 2017 | A1 |
20170156816 | Ibrahim | Jun 2017 | A1 |
20170189126 | Weir | Jul 2017 | A1 |
20170202629 | Maillet et al. | Jul 2017 | A1 |
20170209222 | Gassner et al. | Jul 2017 | A1 |
20170212723 | Atarot et al. | Jul 2017 | A1 |
20170215825 | Johnson et al. | Aug 2017 | A1 |
20170215826 | Johnson et al. | Aug 2017 | A1 |
20170215827 | Johnson et al. | Aug 2017 | A1 |
20170231710 | Scholl et al. | Aug 2017 | A1 |
20170245946 | Tabandeh et al. | Aug 2017 | A1 |
20170245951 | Crawford et al. | Aug 2017 | A1 |
20170258426 | Risher-Kelly et al. | Sep 2017 | A1 |
20170258526 | Lang | Sep 2017 | A1 |
20170258535 | Crawford et al. | Sep 2017 | A1 |
20170265952 | Donhowe et al. | Sep 2017 | A1 |
20170273748 | Hourtash et al. | Sep 2017 | A1 |
20170296277 | Hourtash et al. | Oct 2017 | A1 |
20170312032 | Amanatullah et al. | Nov 2017 | A1 |
20170333137 | Roessler | Nov 2017 | A1 |
20170348061 | Joshi et al. | Dec 2017 | A1 |
20170360493 | Zucher et al. | Dec 2017 | A1 |
20180008355 | Mozes et al. | Jan 2018 | A1 |
20180042464 | Arai et al. | Feb 2018 | A1 |
20180049825 | Kwon et al. | Feb 2018 | A1 |
20180064496 | Hladio et al. | Mar 2018 | A1 |
20180064497 | Hussain et al. | Mar 2018 | A1 |
20180066794 | Okuda et al. | Mar 2018 | A1 |
20180158201 | Thompson | Jun 2018 | A1 |
20180200016 | Chappuis | Jul 2018 | A1 |
20180249981 | Johnson et al. | Sep 2018 | A1 |
20180325610 | Cameron et al. | Nov 2018 | A1 |
20190274765 | Crawford | Sep 2019 | A1 |
20210244494 | Wada | Aug 2021 | A1 |
Number | Date | Country |
---|---|---|
1536975 | Oct 2004 | CN |
1714742 | Jan 2006 | CN |
202027725 | Nov 2011 | CN |
102596062 | Jul 2012 | CN |
102612350 | Jul 2012 | CN |
102933163 | Feb 2013 | CN |
104334110 | Feb 2015 | CN |
104994805 | Oct 2015 | CN |
105101903 | Nov 2015 | CN |
106163446 | Nov 2016 | CN |
106691600 | May 2017 | CN |
106999245 | Aug 2017 | CN |
209153975 | Jul 2019 | CN |
107847275 | Oct 2020 | CN |
102014221469 | Apr 2016 | DE |
1103223 | May 2001 | EP |
1346687 | Sep 2003 | EP |
1523950 | Apr 2005 | EP |
2468207 | Jun 2012 | EP |
2471483 | Jul 2012 | EP |
3181085 | Jun 2017 | EP |
3517069 | Jul 2019 | EP |
107545585 | Jan 2018 | GN |
3-118053 | May 1991 | JP |
11-313837 | Nov 1999 | JP |
2001135734 | May 2001 | JP |
2002253574 | Sep 2002 | JP |
2004518475 | Jun 2004 | JP |
2005-533579 | Nov 2005 | JP |
2007-044488 | Feb 2007 | JP |
2007-531543 | Nov 2007 | JP |
2007534351 | Nov 2007 | JP |
2007537835 | Dec 2007 | JP |
2008-507361 | Mar 2008 | JP |
2008188417 | Aug 2008 | JP |
2008-538184 | Oct 2008 | JP |
2009537229 | Oct 2009 | JP |
2011-120782 | Jun 2011 | JP |
2011-517594 | Jun 2011 | JP |
2012075507 | Apr 2012 | JP |
2013-541365 | Nov 2013 | JP |
2014036700 | Feb 2014 | JP |
2014097220 | May 2014 | JP |
2015-504721 | Feb 2015 | JP |
201536161 | Feb 2015 | JP |
2015100677 | Jun 2015 | JP |
2015119968 | Jul 2015 | JP |
2015521084 | Jul 2015 | JP |
2015528713 | Oct 2015 | JP |
2015-534480 | Dec 2015 | JP |
2016043211 | Apr 2016 | JP |
2016185225 | Oct 2016 | JP |
2016-193222 | Nov 2016 | JP |
2016193222 | Nov 2016 | JP |
2016539681 | Dec 2016 | JP |
2017087313 | May 2017 | JP |
2017176848 | Oct 2017 | JP |
2017530842 | Oct 2017 | JP |
2017223657 | Dec 2017 | JP |
2018011938 | Jan 2018 | JP |
2018-027288 | Feb 2018 | JP |
2018516107 | Jun 2018 | JP |
2018-114283 | Jul 2018 | JP |
2018523516 | Aug 2018 | JP |
2018-202156 | Dec 2018 | JP |
03007198 | Jan 2003 | WO |
2005039417 | May 2005 | WO |
2009092164 | Jul 2009 | WO |
20090126953 | Oct 2009 | WO |
2011128766 | Oct 2011 | WO |
2012050634 | Apr 2012 | WO |
2013114823 | Aug 2013 | WO |
2013118047 | Aug 2013 | WO |
2013192598 | Dec 2013 | WO |
2014010760 | Jan 2014 | WO |
2014139023 | Sep 2014 | WO |
2015023665 | Feb 2015 | WO |
2015052718 | Apr 2015 | WO |
2015061638 | Apr 2015 | WO |
2015079775 | Jun 2015 | WO |
2015142762 | Sep 2015 | WO |
201613049 | Jan 2016 | WO |
2016087539 | Jun 2016 | WO |
2016114834 | Jul 2016 | WO |
2016152255 | Sep 2016 | WO |
2016154557 | Sep 2016 | WO |
2016170372 | Oct 2016 | WO |
2017221257 | Feb 2017 | WO |
2017127202 | Jul 2017 | WO |
2017147596 | Aug 2017 | WO |
2017186799 | Nov 2017 | WO |
2017204832 | Nov 2017 | WO |
2018183461 | Oct 2018 | WO |
Entry |
---|
US 8,231,638 B2, 07/2012, Swarup et al. (withdrawn) |
Markelj et al.: “A review of 3D/2D registration methods for image-guided interventions”, Medical Image Analysis, Oxford University Press, Oxford, GB, vol. 16, No. 3,pp. 642-661, Apr. 1, 2012. |
Gong Ren Hui et al.: “Interactive initialization of 2D/3D rigid registration”, Medical Physics, AIP, Melville, NY, US, vol. 40, No. 12, 14 pages, Dec. 2013. |
Dumenil A et al.: “A versatile intensity-based 3D/2D rigid registration compatible with mobile C-arm for endovascular treatment of abdominal aortic aneurysm”, International Journal of Computer Assisted Radiology and Surgery, Springer, DE, vol. 11, No. 9, pp. 1713-1729, May 26, 2016. |
Alk et al., “Smart Device Assisted Method for Rod Length and Rod Radius Measurement in Percutaneious Pedicle Screw Surgery”, Prizeglad Elektrotechniczny, vol. 3, Mar. 5, 2016, pp. 30-33. |
Marintschev et al.: “Navigation of vertebra-pelvic fixations based on CT-fluoro macthing”, European Spine Journal, Springer, Berlin, DE, vol. 19, No. 11, pp. 1921-1927, Jun. 16, 2010. |
Andreas Alk et a.: “Smart Device Assisted Method for Rod Length and Rod Radius Measurement in Percutaneous Pedicle Screw Surgery”, Przeglad Elektrotechniczny, vol. 3, Mar. 5, 2016 (Mar. 5, 2016), pp. 30-33, XP055668769, PO ISSN: 0033-2097, DOI: 10.15199/48.2016.03.07. |
Number | Date | Country | |
---|---|---|---|
20180296283 A1 | Oct 2018 | US |
Number | Date | Country | |
---|---|---|---|
61800527 | Mar 2013 | US | |
61662702 | Jun 2012 | US | |
62634245 | Feb 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15609334 | May 2017 | US |
Child | 16002047 | US | |
Parent | 15157444 | May 2016 | US |
Child | 15609334 | US | |
Parent | 15095883 | Apr 2016 | US |
Child | 15157444 | US | |
Parent | 14062707 | Oct 2013 | US |
Child | 15095883 | US | |
Parent | 13924505 | Jun 2013 | US |
Child | 14062707 | US |